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Abstract
A PCR screen, conducted in a previous study, to identify novel candidates 
involved in regulating the survival and growth of developing neurons, identified 
transcripts for the tumor necrosis factor receptor (TNFR) superfamily member 
receptor activator of NF-kB (RANK) in the experimentally tractable sensory 
neurons of the mouse nodose, trigeminal and superior cervical ganglia. 
Immunohistochemistry revealed coexpression of RANK, together with its ligand, 
RANKL, and osteoprotegerin (OPG), a decoy receptor, in all nodose, trigeminal 
and superior cervical gangia neurons in neonates. Over-expressing RANK 
inhibited BDNF- and CNTF-promoted neurite growth in nodose neurons, and 
NGF-promoted neurite growth in SCG and trigeminal neurons, without affecting 
neuronal survival. This effect was seen across a range of developmental ages, 
from embryonic timepoints, to postnatal ages, suggesting a fundamental role for 
this receptor in regulating neurotrophin-mediated neurite growth.
Investigations revealed the requirement of TRAF2, NIK, IKKp and NF-kB, 
but not TRAF6 or IKKa, for RANK-mediated inhibition of BDNF-mediated neuritic 
outgrowth from nodose neurons at a time when neurons are extending axons 
and ramifying in their targets.
Exploration of other possible RANK signalling mediators revealed a role 
for the important intracellular kinases, MEK and Akt, in the regulation of BDNF- 
mediated neuritic outgrowth from early postnatal nodose neurons. Akt was found 
to positively regulate BDNF-mediated neuritic outgrowth, while MEK negatively 
regulates the outgrowth mediated by this neurotrophin.
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Chapter 1
General Introduction
1.1 Brief overview of neuronal development
1.1.1 Introduction
The development of the mammalian brain and nervous systems is one of the 
most complex processes in nature requiring the formation, growth and 
refinement of an astonishing number of cells, around 1011, and many more times 
that number of connections. The entire process requires an intricately controlled 
series of events to occur in sequence: the birth of neurons from progenitors, 
subsequent migration and the extension of processes to establish functional 
connections with target tissues. Firstly, I will provide an overview, in brief, of the 
events that occur during the stages of neuronal development, then I will detail 
the key players in the regulation of neuronal survival and neuritic outgrowth from 
these populations. Finally, I will discuss several families of extracellular and 
intracellular signalling molecules that are directly relevant for the research 
reported in this thesis, namely, the tumor necrosis factor (TNF) and TNF receptor 
(TNFR) superfamilies, the nuclear factor-KB (NF-kB) transcription factor family, 
the receptor activator of NF-kB (RANK) signalling trio, the ERK1/ERK2 members 
of the MAPK family, and an important protein kinase, Akt, involved in intracellular 
signalling. The role of these proteins in the regulation of neuritic growth and 
neuronal survival are the focus of this research.
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1.1.2 Neural induction
Following many rounds of division, the fertilized vertebrate embryo forms three 
layers: an internal endoderm, an intermediate mesoderm and an external 
ectoderm, in a process known as gastrulation. The vertebrate nervous system 
arises from a sheet of ectoderm cells, which lie along the dorsal midline, at the 
gastrula stage. These cells form the neural plate, which become the neural tube 
through the process of neurulation (Jessell & Sanes, 2000a). During neurulation, 
the neural plate buckles at the midline forming the neural fold. The dorsal tips of 
the neural folds then fuse, creating the tubular structure of the neural tube. Fig. 
1A displays a schematic overview of this process, which will be reviewed in more 
detail in a subsequent section.
The neural tube forms the vertebrate central nervous system (CNS), the caudal 
region becoming the spinal cord and the rostral end becoming the brain (Jessell 
& Sanes, 2000a). The early stages of neural development are characterized by a 
rapid increase in cell numbers, and an uneven expansion of the different 
segments of the neural tube. Initially the rostral part of the neural tube forms 
three vesicles: the forebrain, midbrain and hindbrain vesicles, otherwise known 
as the prosencephalon, mesencephalon and rhombencephalon (Fig. 1B). The 
prosencephalon subsequently subdivides into the right and left telencephalic 
vesicles and the centrally located dicencephalon and the rhombencephalon 
subdivides into the rhombencephalon and myencephalon (Eagleson & Harris, 
1990).
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Neural tube'
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Ectoderm'
lateral^
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Three vesicle stage
—  Rhombencephalon
Caudal neural tube
Figure 1: Formation of the neural tube and early vesicle formation. A.
The neural plate (A) forms as a flat epithelial sheet that then rises (B) and 
folds towards the midline joining in the middle to form the neural tube (C). 
B. Three vesicle stage of early brain development. From Jessell & Sanes, 
2000a.
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The formation of the nervous systems is regulated by a region of the axial 
mesoderm known as the organizer (Harland, 2000). A series of pioneering 
experiments, conducted by Spemann and Mangold in the 1920s, demonstrated 
the role this region plays (Weinstein & Hemmati-Brivanlou, 1999). The dorsal 
blastophore lip was grafted into the region of a host amphibian embryo that 
usually gives rise to the ventral epidermis and the result was the formation of a 
second embryonic axis, including an entire nervous system. Transplanted tissue 
became the notochord, following normal development, however, host ectodermal 
cells formed the second embryonic axis. These experiments suggest that the 
organizer recruits surrounding ectoderm into a patterned neural tube.
The patterning of the nervous system depends on several inductive signals, 
which block the action of members of the Bone Morphogenic Protein (BMP) 
family such as BMP2 and BMP4 (Chitnis, 1999). The ectoderm is divided into 
three dorsoventral zones by BMP signalling from which the neural plate, neural 
crest and epidermis form. In order for cells in the neuroectoderm to become 
neurons they must adopt a neural fate and neural inducers such as chordin 
(Sasai et al., 1994), follistatin (Hemmati-Brivanlou & Melton, 1994) and noggin 
(Lamb et al., 1993) act as functional antagonists of BMPs. Other neural inducers 
include members of the Xnr3 family and the nodal antagonists Lefty and Antivin 
(Hansen et al., 1997; Meno et al., 1999) The ectoderm responds to BMP 
activation in a dose-dependent manner and a higher level of BMP activity 
correlates with an ectodermal fate, while a lower correlates with neuronal. BMP
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signalling is constitutively active and neural inducers suppress BMP signalling 
inducing the expression of a number of transcription factors including Sox and 
Zic genes (Chitnis, 1999). These factors then promote the expression of genes 
required for neural and neuronal differentiation in the dorsal ectoderm. Other 
factors, such as fibroblast growth factors (FGFs) and Wnts are also necessary 
for patterning of the nervous system (Chitnis, 1999).
1.1.3 Formation of the neural tube
Neurulation occurs in four phases: formation of the neural plate or neural 
induction, shaping of the neural plate, bending of the neural plate and closure of 
the neural groove (Colas & Schoenwolf, 2001). The neural tube arises from 
dorsal midline ectodermal cells which thicken to become an initially 
pseudostratified epithelial area. Shaping of the neural plate involves apicobasal 
thickening of the ectoderm and extension so that it narrows mediolaterally and 
elongates rostrocaudally. Neural folds then form at the lateral extremes of the 
plate and begin to elevate and converge at the midline, establishing the neural 
groove. In humans, bending of the neural tube completes at the upper cervical 
region first. Bending occurs in two stages: furrowing and folding. Furrowing 
creates hinge points, three localized regions lying at the prechordal plate and 
paired dorsolateral hinge points, and folding occurs around these points. Folding 
around the median hinge point is referred to as elevation, and folding around the 
dorsolateral points, convergence.
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Bending of the neural plate is driven by changes in neuroepithelial cells and 
changes in the adjacent cells of the epidermis. Furrowing at the median hinge 
point requires an inductive signal from the underlying notochord, in the form of 
Sonic Hedgehog, which is also involved in the formation of the floor plate of the 
neural tube (Jessell & Sanes, 2000). Ultimately, the neural folds are brought into 
contact resulting in fusing of the folds and the cells adhering to one another. This 
establishes the roof of the neural tube and neural crest cells form as the neural 
folds are elevating (Colas & Schoenwolf, 2001).
The failure of closure of the neural tube results in birth defects known as neural 
tube defects (NTDs) the most common of which are anencephaly, a failure of the 
rostral neural tube to close, and myelomenigocoele, failure of fusion of the 
vertebral neural tube. Null mice have been generated that display NTDs 
implicating a range of factors in the regulation of closure of the neural tube 
(Copp, 2005).
It is clear that the position of cells in the neural tube is vital to their fate and that 
dorsoventral and anteroposterior positioning determines regional identity (Jessell 
& Sanes, 2000). Exposure to signalling molecules that are regionally restricted, 
and operate over these two axes, determine the fate of the cells. Important 
molecules include transforming growth factors (TGFs) (such as BMPs), 
hedgehogs, FGFs, Wnts and retinoids are all vital for the specification of cell fate 
(Lumsden & Krumlauf, 1996; Lee & Jessell, 1999).
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1.1.4 Neuronal migration
The migration of neuronal and non-neuronal cells during development is a key 
process in the development of the CNS. Most central neurons arise in the 
ventricular zone and migrate to their final location before differentiating (Jessell & 
Sanes, 2000). These neurons then migrate along the surfaces of radial glial 
cells, using these cells as migratory guides, from ventricle to pia (Hatten, 1999). 
Once neurons reach the cortex, they organise themselves into layers with newer 
cortical neurons forming the outer zone, in an “inside-out” order (Angevine & 
Sidman, 1961).
There are two types of neuronal migration: the aforementioned radial migration 
along radial glial cells, in a direction perpendicular to the surface of the brain and 
tangential migration in line with the surface of the brain. The vast majority of 
neurons migrate via radial migration including cells of the cerebellar cortex, 
spinal cord, striatum and thalamus (Hatten, 1999). Populations that migrate via 
tangential migration include connections established between the median 
ganglionic eminence and the neocortex and hippocampus, and between the 
lateral ganglionic eminence and the olfactory bulb.
Several mouse models have facilitated our understanding of the process of 
neuronal migration. Reeler, a naturally occurring mouse mutant, displays an 
inversion of the normal “inside out” order of cortical neurons, along with a severe
cerebellar phenotype (Marin-Padilla, 1978). Another mouse model that has 
provided insights into neuronal migration is weaver, a model in which granule cell 
precursors die in ectopic positions due to an inability to migrate along glial fibres 
(Gao et al., 1993). In humans, the disorder periventricular heterotopia is caused 
by the failure of postmitotic neurons to leave the ventricular zone (Ekssioglu et 
al., 1996). Another disorder of neuronal migration in humans is lissencephaly, a 
condition that causes smoothening of the cortex and the presence of a four- 
layered cortex, in contrast with the usual six layers (Gleeson & Walsh, 2000).
1.1.5 Axonal growth and guidance
The establishment of functional connections requires the guidance of axons from 
neurons to their targets, over tremendous relative distances. Axons are guided 
by molecular cues encountered in their environments and there are four different 
mechanisms that guide growth cones: contact mediated attraction,
chemoattraction, contact-mediated repulsion and chemorepulsion (Goodman, 
1996). Guidance cues can be divided into four categories: long and short range 
attractive and long and short range repulsive cues. Long range attractive cues 
include netrins and short range attractive cues include laminins. Semaphorins 
and their receptors are an example of long range repulsive cues, while short 
range repulsive cues include ephrins and their receptors the Eph kinases. Other 
cues include DCC/neogenin, and the Unc5s, the slits and their receptors, the 
robos and the integrins (Jessell & Sanes, 2000).
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Two of the most important regulators of axon guidance are the ephrins and their 
receptors, the Eph kinases, and G-protein-coupled receptors. Ephrins act in a 
gradient along the anteroposterior axis of the tectum, along with Eph kinases, 
along the anteroposterior axis of the retina, to help guide axons to their targets. 
G-protein-coupled receptors play critical roles in the guidance of olfactory 
receptors to specific targets within the brain, though in a very different way than 
the molecular gradients of other chemoattractants and the exact mechanism of 
action remains a mystery. Figure 2 shows a simplified diagram of some of the 
key regulators of axonal attraction and repulsion. The intracellular mechanisms 
that control neuronal growth will be discussed in a subsequent section.
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Short-range 
attractive cues 
(e.g. laminins)
+  +  +
Long-range
attractive
cues
{e.g. netrins)
o Short-range 
inhibitory cues 
(e.g. ephrins) _
Long-range
repulsive
cues
(e.g. semaphores)
Fig 2: Molecular mechanisms of axonal growth and guidance.
Four major classes of signals contribute to axon guidance: short and 
long range attractors and repulsors. An example is listed for each 
class. Adapted from Jessell & Sanes, 2000.
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1.2 Organisation and development of the peripheral nervous 
system
1.2.1 Introduction
The CNS consists of the brain and the spinal cord and the peripheral nervous 
system (PNS) provides the link between the CNS and the periphery. The PNS 
can be divided into two subdivisions: the autonomic and the somatic nervous 
systems. The somatic nervous system contains neurons of the dorsal root 
ganglia (DRG) and cranial sensory ganglia (CG) which convey sensory 
information to the CNS and motoneurons whose cell bodies reside in the CNS 
and innvervate skeletal muscle. The autonomic nervous system consists of the 
sympathetic, parasympathetic, and enteric nervous systems and regulates motor 
control of the viscera, smooth muscles and exocrine glands. The work contained 
in this thesis focuses on the role of the RANK receptor, and its associated 
ligands, in the regulation of neuritic growth from discrete populations of sensory 
and sympathetic neurons during development. The role of a MAPK family 
member, ERK, and the Akt family will also be explored. In this section I shall 
provide an overview of the organisation of the PNS and of the embryonic 
development of this nervous system.
1.2.2 Organisation of the somatic PNS
The somatic PNS is organized into twelve pairs of cranial nerves and thirty-one 
pairs of spinal nerves and these provide the CNS with sensory information from 
a range of inputs and innervate skeletal muscle throughout the body. There are
12
eight pairs of cranial sensory ganglia and the axons of these nerves form part of 
five of the twelve cranial nerves. The trigeminal ganglion is located on cranial 
nerve V and innervates mechanoreceptors, thermoreceptors and nociceptors of 
the face, nasal and oral cavities. The geniculate ganglion is located on cranial 
nerve VII and this nerve cluster innervates taste buds on the anterior two thirds 
of the tongue. Cranial nerve VIII contains fibres of the vestibular and spiral 
ganglia, which innervate inner ear hair cells. The petrosal ganglion, located on 
cranial nerve IX, innervates sensory receptors of the carotid body, as well as the 
taste buds in the posterior one third of the tongue. The superior 
glossopharyngeal ganglion is part of cranial nerve IX and innervates the skin of 
the pinna and tympanic membrane. Finally, the jugular and nodose ganglia form 
part of cranial nerve X and innervate various sensory targets in the pharynx, 
thorax and abdomen. Figure 3 illustrates the organization of the cranial nerves.
Each spinal nerve connects to the spinal cord via a dorsal root and a ventral root. 
The dorsal root consists of sensory fibres and their cell bodies, which are located 
in the dorsal root ganglia. The ventral root contains motor fibres with cell bodies 
located in the ventral grey matter. Just before the nerve leaves the vertebral 
column, via an intervertebral foramen, the roots join to form the spinal nerve and 
each spinal nerve then splits in dorsal and ventral rami, which consist of mixed 
sensory and motor fibres.
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Fig 3: Organisation of the cranial nerves. An illustration depicting the 
cranial nerves and the tissues they innervate (www.web-books.com).
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1.2.3 Organisation of the autonomic nervous system
The autonomic nervous system (ANS) consists of three subdivisions: the 
sympathetic, parasympathetic and enteric systems. These regulate visceral 
sensation, motor control of the viscera, smooth muscles and exocrine glands. 
The sympathetic and parasympathetic nervous systems maintain a balance in 
the body between energy consumption and the conservation of resources and 
the enteric nervous system regulates smooth muscle function in the gut.
The divisions of the ANS are organised in distinct anatomical ways. Unlike motor 
neurons of the somatic nervous system, whose neurons project directly from the 
CNS to their targets, motor neurons of the sympathetic and parasympathetic 
nervous systems are located in autonomic ganglia outside the CNS (Iverson et 
al., 2000). The cells bodies of preganglionic neurons are located in the spinal 
cord or brain stem, and their axons synapse with postganglionic neurons whose 
cell bodies are located in autonomic ganglia. Preganglionic sympathetic fibers 
emerge from thoracic and upper three lumbar segments and synapse with 
neurons in the paravertebral sympathetic chain ganglia and prevertebral ganglia. 
The preganglionic synapses release the neurotransmitter acetylcholine (ACh), 
while most postganglionic synapses utilise noradrenaline.
Preganglionic parasympathetic nerves originate from the brainstem and sacral 
spinal cord and travel in sacral spinal nerves or cranial nerves III, VII, IX and X.
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Parasympathetic preganglionic neurons lie within the Sacral 2-4 segments of the 
spinal cord and within the brain stem, and synapse on postganglionic neurons 
near the organs they innervate. Cranial nerve X innervates the heart, lungs, 
stomach, upper intestine and ureter, while the remaining cranial nerves innervate 
the iris and salivary glands. As with the sympathetic nervous system, 
preganglionic neurons liberate Ach onto their postganglionic partners. However, 
unlike sympathetic neurons, postganglionic neurons of the parasympathetic 
nervous system release Ach (Nolte, 1999). Figure 4 shows an illustration of the 
organization of the DRG and Figure 5 shows a schematic illustration of the 
anatomical organisation of the sympathetic and parasympathetic divisions of the 
PNS.
The enteric nervous system consists of a mostly autonomous network that 
regulates the function of the gastrointestinal tract, pancreas and gallbladder. It 
contains local sensory neurons and interneurons, along with motor neurons, that 
extend along the entire length of the gastrointestinal tract in two plexuses: the 
myenteric plexus and the submucous plexus and these regulate the secretory 
functions of the gut and gut motility, respectively.
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Fig 4. Anatomical organisation of the DRG.
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Fig 5: Sympathetic and parasympathetic divisions of the ANS. Diagram 
showing the organisational structure of the sympathetic (left) and 
parasympathetic (right) nervous systems and some of the targets they 
innervate. From Iverson et al., 2000.
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1.2.4 Development of the peripheral nervous system
Neural crest cells differentitate into sensory neurons, postganglionic autonomic 
neurons and Schwann cells of the PNS. Sensory neurons of the PNS arise from 
two sources: the neural crest and the neurogenic placodes (Davies, 1994). 
Neural crest cells also give rise to pigment cells, catecholamine-secreting cells of 
the adrenal medulla and some cranial cartilage (Selleck & Bronner-Fraser,
1995).
The neural crest is a migratory cell population that emerges from the dorsal 
neural tube and rapidly migrates along several pathways into the periphery 
(Jessell & Sanes, 2000a). The neural crest can be divided into four functional 
domains: the cephalic, trunk, vagal and sacral, and cardiac neural crests. Cells 
of the trunk neural crest begin to migrate as the neural tube closes and they 
follow two paths: the dorsolateral and the ventral pathways. Migrating cells along 
the dorsolateral pathway produce melanocytes and travel into the epidermis. 
Cells that follow the ventral pathway become the DRG, sympathetic ganglia, and 
the adrenal medulla. Cranial neurons are derived from the cephalic neural crest, 
along with the dorsomedial part of the trigeminal ganglion, the trigeminal 
mesocephalic nucleus and the jugular gangion. Parasympathetic ganglia of the 
gut are derived from the vagal and sacral neural crests. The molecular basis of 
neural crest formation is incompletely understood, although BMP and FGF 
signalling have both been implicated in neural crest induction, as has Wnt
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signalling (Selleck & Bronner-Fraser, 1995; LeBonne & Bronner-Fraser, 1998; 
Brault et al., 2001).
Cranial sensory neurons are derived from two sources: neurogenic placodes, 
thickenings of ectodermal tissue induced by signals from the surrounding 
tissues, and neural crest cells. Neurogenic placodes can be divided into two 
groups: dorsolateral and epibranchial, based on their position in the developing 
cranium (Ayer-Le Lievre & Le Douarin, 1982). Dorsolateral placodes give rise to 
the vestibular and ventrolateral trigeminal ganglia and epibranchial to nodose, 
petrosal and geniculate ganglia.
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1.3 Regulation of neuronal survival in the PNS
1.3.1 Introduction
Key factors in the regulation of apoptosis have been identified and include 
members of the Bcl-2, apototic protease activating factor (APAF) and caspase 
families (Jessell & Sanes, 2000; Cory et al., 2003). Caspases are final common 
agents for programmed cell death (PCD) in cells and Bcl-2 regulates the activity 
of this family. Neurotrophic factors promote the survival of neurons by 
suppressing the action of this apoptotic program. There are two distinct 
pathways crucial for PCD: the intrinsic pathway and the extrinsic pathway. The 
intrinsic pathway is activated by developmental cues and cytotoxic insults and is 
tightly controlled by Bcl-2 family member proteins. The extrinsic pathway is 
triggered by death receptor activation and leads to the activation of caspases 
independently of Bcl-2. Figure 6 shows a schematic illustration of the way 
apoptosis and members of the Bcl-2 family are modulated by neurotrophins.
The Bcl-2 family can be divided into three sections: pro-apoptotic, anti-apoptotic 
and Bcl-2 homology domain-only (BH-3) proteins (Cory et al., 2003). 
Proapoptotic members include BAX, BAK and BOK; anti-apoptotic include Bcl-2, 
Bcl-XL, Bcl-W and Bcl-B; and BH-3 only proteins include members such as BAD, 
BIK, BID, HRK, BIM, NOXA and PUMA (Reed, 2008). The method of action of 
pro-apototic members, such as BAX, is an interesting one. BAX permeablises 
the membrane of the mitochondria, leading to the release of apoptogenic
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molecules including cytochrome c and DIABLO. Cytochrome c then binds to 
APAF to form the apoptosome, which binds to caspase 9 and promotes 
apoptosis (Youle & Strasser, 2008). In neurons a balance is maintained between 
survival promoting signals such as neurotrophins, and death signals. NGF 
promotes survival by activation of pro-survival pathways including Akt and MAPK 
pathways. These support survival by inhibiting pro-apoptotic pathways such as 
Bad and Forkhead and promoting pro-survival pathways including CREB (Yuan 
& Yankner, 2000).
The exact reason why so many neurons are born that then undergo PCD is still a 
matter for debate. It has been suggested that this allows flexibility within 
neuronal systems and recovery from insult during development (Pettman & 
Henderson, 1998). In the nermatode C. Elegans the number of cells apoptosing 
is surprisingly specific, with 105 out of 1090 neurons undergoing cell death. This 
function is thought to allow the generation of subtly different structures from 
initially similar lineages and the generation of sexually dimorphic structures 
(Bottjer & Arnold, 1997). Knockout mice have been generated for some of the 
key regulators of PCD. Bax knockout mice are relatively normal, as are 
transgenic mice over-expressing Bcl-2 (Knudson et al, 1995; Martinou et al., 
1994) and both mice display increased numbers of neurons but normal life 
spans.
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Fig 6: Extrinsic and intrinsic control of apoptosis. The extrinsic 
pathway of apoptosis can be activated by cell surface receptors such as 
Fas and TNFR1. The intrinsic pathway begins with induction of BH3 and 
the inactivation of various BCL-2 family members, activation of BAX and/or 
BAK. This leads to cytochrome C release, APAF-1 and caspase-3 
activation. From Youle & Strasser, 2008.
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1.3.2 The neurotrophic theory
The neurotrophic theory is one of the fundamental tenets of modern 
neuroscience. The discovery of nerve growth factor (NGF) provided an answer to 
the central question of how the survival of neuronal populations is regulated 
during development (Levi-Montalcini, 1987). Neurons are produced in far larger 
quantities than necessary; therefore a means of matching populations to the 
requirements of their target fields is essential. Target fields produce limiting 
quantities of NGF and other neurotrophins and only neurons that are able to 
obtain a supply of these factors are able to survive. Neurons that are unable to 
secure a supply of survival promoting factors undergo naturally occurring or 
PCD. In this way, the amount of trophic factor available from a target influences 
the resultant size of the innervating population (Davies, 1988; Barde, 1989). 
Figure 7 displays an illustration of this theory.
Since the discovery of NGF a plethora of evidence has increased our 
understanding of the way in which neuronal survival is regulated. Administration 
of anti-NGF antibodies in vivo eliminates sensory and sympathetic neurons 
dependent on NGF, while administration of NGF prevents naturally-occurring 
neuronal death (Levi-Montalcini & Booker, 1960; Yip, et al., 1984; Davies et al.,
2003). Knockout mice lacking NGF or its receptor tyrosine kinase (TrkA) 
decreases sensory and sympathetic NGF-dependent populations (Crowley et al., 
1994; Smeyne et al., 1994). Since the initial publicationn of the neurotrophic
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theory, evidence has arisen that complicates the theory. Neurons require trophic 
support before and after synaptogenesis and from sources other than their target 
fields (Davies, 2003); many neuronal populations switch their neurotrophic 
requirements during development (Buchman & Davies, 1993; Wyatt et al., 1997; 
Kuruvilla et al., 2004) and PNS neurons survive independently of neurotrophic 
factors in vitro at the age when axons are beginning to sprout (Davies, 1994). 
The period of neurotrophin independence correlates precisely with the distance 
required for axons to reach their targets (Davies, 1989; Vogel & Davies, 1994).
25
Meurons approach target
Target source of 
neurotrophic factor
< 1
Degenerating neuron
Limited supply of
neurotrophic factor
Fig 7: The neurotrophic theory. As neurons extend axons towards targets (A) a 
limited amount of survival promoting factor is secreted by the target. Neurons able 
to acquire the factor survive (B), those unable apoptose and neuronal population 
size is matched to target requirements.
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Since the initial discovery of NGF, the neurotrophin family in mammals has been 
expanded to include brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), and neurotrophin-4 (NT-4) (reviewed in Huang & Reichardt, 2001). There 
are also other types of proteins that can regulate survival, development and 
function in the nervous system including the glial-derived neurotrophic factor 
(GDNF) family and the neuropoietic cytokines. The neurotrophic factors can also 
be divided by the sets of neurons that they regulate, with most neurons 
specifically responsive to one or more factors at any specific time. Neurotrophins 
are basic, homodimeric, secreted proteins in the range of 25-27 kDa and are 
derived from the proteolytic cleavage of larger precursors (Davies, 1994). 
Neurotrophins signal via tyrosine kinase receptors of the Trk family and this 
family and its members will be discussed in a subsequent section.
In addition to regulating the survival of neuronal populations during development, 
the neurotrophin family has a range of other functions including the regulation of 
cellular proliferation, process outgrowth, and synaptic plasticity (Davies, 2000; 
Bidel & Barde, 2000; Thoenen, 2000). The original work contained in this thesis 
explores the role of specific receptors and intracellular mediators in the 
regulation of neuronal survival and outgrowth by neurotrophins. The neurotrophic 
requirements of specific ganglia have been well documented. In the following 
section, I will describe the neurotrophic requirements of ganglia that are relevant 
for the work of this thesis. I will then describe the biology of selected 
neurotrophins and their receptors that are relevant for this work.
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1.3.3 Neurotrophic requirements of selected peripheral ganglia
The studies described in this thesis were performed on sensory neurons of the 
mouse nodose ganglion (NG), trigeminal ganglia (TG) and the sympathetic 
neurons of the superior cervical ganglion (SCG).
Nodose neurons are placode derived general visceral sensory neurons that 
innervate most of the thoracic and abdominal viscera. The majority of neurons of 
the mouse nodose ganglion survive and extend neurites when cultured in media 
containing BDNF, at embryonic and postnatal stages (Lindsay & Rohrer, 1985; 
Davies & Lindsay, 1986; Davies et al., 1986; Davies et al., 1993) and 
administration of BDNF in vivo rescues neurons that would other-wise die (Hofer 
& Barde, 1988). The survival of nodose neurons has also been shown to be 
regulated by NT-3 and NT-4 (Hohn et al., 1990; Davies et al., 1993b). Null mice 
have been generated for each of these factors and show increased cell death in 
the nodose population (Ernfors et al., 1994a; Liu et al., 1995; Erickson et al., 
1996; Elshamy et al., 1997; Forgie et al., 2000). A small subpopulation of nodose 
neurons are also supported by NGF, early in development, and NGF knockout 
mice show a small decrease in the size of the nodose population (Forgie et al., 
2000). Other factors have also been shown to support subpopulations of nodose 
neurons including the neurotrophic cytokines, CNTF, LIF, OSM and CT-1 
(Horton et al., 1993; Davies et al., 1993; Horton et al., 1998). In vitro nodose 
neurons can be supported by BDNF and these neurotrophic cytokines.
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The neurons of the TG are a discrete population of cutaneous sensory neurons 
that innervate the anterior part of the head (Davies, 2003). During early 
embryonic development trigeminal neurons are dependent upon a supply of 
BDNF and NT-3, but switch their dependence to NGF later in development 
(Buchman & Davies, 1993). These changes in neurotrophin responsiveness are 
mirrored by changes in expression of the Trk receptors in the neurons. Early in 
development TrkB and TrkC are highly expressed but later on the expression of 
these two receptors decreases, and the expression of TrkA mRNA increases 
(Ernfors et al., 1992; Arumae et al., 1993; Wyatt & Davies, 1993).
Neurons of the sympathetic SCG are supported by a variety of factors 
throughout their development. Both artemin and hepatocyte growth factor play 
roles in the development of this neuronal population (Maina et al., 1998; Andres 
et al., 2001; Baloh et al., 1998). SCG neurons respond to NGF at E14 and are 
dependent on this neurotrophin for survival during their development (Wyatt & 
Davies, 1995). Later in the development of this neuronal population SCG 
neurons respond to both NGF and NT-3 and this period corresponds to the 
expression of TrkA (Wyatt et al., 1997; Kuruvilla et al., 2004). Postnatal SCG 
neurons have also been shown to respond to LIF, CNTF and HGF (Kotzbauer et 
al., 1994; Thompson et al., 2004).
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1.3.4 NGF
This neurotrophin was first discovered was by Rita Levi-Montalcini & Viktor 
Hamburger during studies of sensory and sympathetic ganglia of eight-day chick 
embryos (Levi-Montalcini, 1953). When embryonic day 8 (E8) ganglia were 
cultured close to fragments of mouse sarcoma 180 or 37, a dense halo of nerve 
fibres was seen in 12-24 hours. This was found to be due to the presence of a 
protein later dubbed “the” nerve growth factor. This factor was later isolated and 
purified so that biochemical and other studies could be performed (Cohen et al., 
1954). Injection of NGF-specific antibodies into newborn mammals resulted in a 
marked loss of sympathetic neurons confirming the in vivo relevance of NGF 
(Levi-Montalcini & Booker, 1960).
Additional experiments clarified the role of NGF in the development of neuronal 
populations. Administration of NGF during the period of naturally occurring 
neuronal cell death prevents the death of these neurons (Davies, 2003). Mice 
lacking the NGF or the receptor tyrosine kinase (TrkA) genes show decreased 
numbers of sensory neurons and sympathetic neurons (Crowley et al., 1994; 
Smeyne et al., 1994). NGF is crucial for the development of the nervous system, 
especially for the survival of small nociceptive sensory neurons and sympathetic 
neurons (Farinas, 1999). As with other neurotrophins, NGF is synthesized in a 
precursor form and then cleaved to the mature form. NGF has been found to be
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expressed in many regions of the CNS including neocortex, basal forebrain and 
hippocampus (Johnston, 1987).
1.3.5 BDNF
BDNF was first isolated from mammalian brain and was subsequently found to 
prevent the death of sensory neurons in vivo (Barde et al., 1982; Hofer & Barde, 
1988). BDNF supports the survival of neuronal populations including trigeminal 
neurons, which respond to BDNF for a restricted period in their development, 
and neurons of the nodose, petrosal, geniculate and vestibular ganglia (Lindsay 
et al., 1985a; Davies et al., 1986b; Horton et al., 2001; Hofer & Barde, 1988; 
Tucker et al., 2001). BDNF also promotes neurite growth from neurons of the 
nodose, DRG, sympathetic and vestibular ganglia (Paves et al., 1997; Lentz et 
al., 1999; Tucker et al., 2001).
As with NGF, BDNF is synthesised as a precursor and then cleaved to form the 
mature, biologically active form (Lee et al., 2001), and BDNF shares 50% 
homology with NGF (Barde et al., 1982). BDNF is widely expressed in CNS 
regions, including the cerebral cortex, cerebellum, hippocampus, basal forebrain, 
hypothalamus striatum, and brainstem (Kawamoto, et al., 1996). BDNF knockout 
mice display severe defects in sensory neuronal populations essential for 
survival (Jones et al., 1994; Ernfors et al., 1994a). BDNF has also been 
implicated in a variety of developmental processes including proliferation,
31
learning and memory, long term potentiation, and synaptic plasticity (Tapia- 
Arancibia et al., 2004; Kaftiz et al., 1999; Bramham et al., 2005).
1.3.6 CNTF
Ciliary neurotrophic factor (CNTF) is a neurotrophic cytokine that supports the 
survival a variety of neuronal populations in vitro including nodose neurons and 
neurons of the parasympathetic ciliary ganglion, and promotes the survival of a 
subset of trigeminal neurons during the late fetal period (Barbin et al., 1984; 
Horton et al., 2001). CNTF has also been implicated in the regulation of neurite 
growth and axon regeneration in the developing and mature nervous systems 
(Siegel et al., 2000). CNTF was purified from embryonic chick eye (Barbin et al., 
1984) and bears similarity to other neuropoietic cytokines including LIF, IL-6, 
OSM and G-CSF (Taga & Kishimoto, 1992). CNTF binds to a receptor complex 
consisting of gp130, leukaemia inhibitory factor receptor p, and CNTF receptor a 
(Stahl & Yancopoulos, 1994).
1.3.7 Trk receptors
Neurotrophins signal via a family of receptors known as the tropomysosin-related 
kinase (Trk) receptors as well as the common neurotrophin receptor p75, which 
is a member of the TNFR superfamily. The Trk family consists of 3 receptors: 
TrkA, TrkB and TrkC. Trk A was the first of these receptors to be discovered, as 
an oncogene product in a human colon carcinoma (Martin-Zanca et al, 1986; 
Kuruvilla et al., 2004). NGF binds to and activates TrkA (Kaplan et al., 1991;
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Klein et al., 1991). TrkB and TrkC were identified by homology cloning to and 
were found to be receptors for BDNF (TrkB) and NT4 (TrkB), and NT3 (TrkC) 
respectively (Huang & Reichardt, 2001; Bibel & Barde, 2000). Figure 8 shows an 
illustration of the neurotrophins and the respective Trks they bind.
Activation of the Trk receptors leads to phosphorylation of tyrosine residues on 
the cytoplasmic domains of the receptors. This is turn leads to recruitment of 
adaptor proteins and coupling to intracellular signalling cascades including the 
Ras/ERK (extracellular signal-regulated kinase) protein kinase pathway, the 
phosphatidylinositol-3-kinase (PI3k)/Akt pathway and phospholipase C (PLC)-yl 
(Huang & Reichardt, 2003). Akt and ERK have been shown to play a role in the 
regulation of survival and neuritic outgrowth mediated by neurotrophins and 
other factors in a variety of neurons (Huang & Reichardt, 2003). NGF was shown 
to be internalized by a receptor-dependent process, which was energy and 
microtubule dependent, and transported along axons for long distances in 
signalling endosomses to the cell soma (Shooter, 2001; Reichardt, 2006). Local 
signalling was shown to regulate the motility of growth cones, while cell survival 
and gene expression is regulated by signalling in the cell soma.
1.3.8 p75
The p75 common, low-affinity receptor binds all neurotrophins with equal 
effectiveness (Davies, 1994; Davies, 2003). p75 was cloned in the mid-eighties 
as a receptor for NGF (Chao et al., 1986; Radeke et al., 1987) and has since
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been shown to enhance the survival response of embryonic sensory and 
postnatal sympathetic neurons to NGF (Lee et al., 1992; Lee et al., 1994; 
Davies, 1994; Lee et al., 1994a). However, there is also evidence that p75 
promotes neuronal death in the absence of Trk signalling (Rabizadeh et al., 
1993; Barrett et al., 1994; Domeniconi et al., 2007).
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Fig 8: The neurotrophins and their receptors. Schematic illustration of the 
neurotrophins and the receptors they bind to. NGF binds TrkA, BDNF and NT-4 
bind TrkB and NT-3 binds all 3 Trk receptors, but TrkC with more specificity. 
Adapted from Jessell & Sanes, 2000c.
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1.4 Regulation of neurite outgrowth
1.4.1 Axon extension and guidance
The establishment of functional connections is a key step in the development of 
the nervous systems. Neurons must locate and extend axons towards targets 
over enormous distances and specific molecular cues guide axons. The terminal 
segment of the axon is a specialised structure termed the growth cone and this 
structure navigates through the embryonic environment towards its target. The 
growth cone displays a distinctive shape; that of an outstretched hand, extending 
“fingers” termed filopodia (Sanes & Jessell, 2000). The characteristic structure of 
the growth cone is shaped by fibrillar structures including microfilamentous actin 
and microtubules and contains receptors for guidance cues. The filopodia reach 
into the external environment and detect these extrinsic cues, some of which 
attract and others repel (Gallo & Letourneau, 1998). These cues include 
semaphorins, netrins, slits, which are almost all secreted molecules, ephrins, 
which are tethered to the plasma membrane, and mophogens and their 
associated receptor systems (Goodman, 1996; Grunwald & Klein, 2002).
1.4.2 The role of neurotrophic factors in regulating neurite outgrowth from 
PNS neurons
The role of neurotrophic factors in promoting neurite outgrowth in vitro is well 
established (Tucker et al., 2001; Davies, 2000; Kuruvilla et al., 2004). Due to the 
regulation of neuronal survival by these factors, their role in neurite growth in
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vivo is more complex. The ability of neurons to initially extend axons in the 
absence of neurotrophin/Trk signalling also further complicates matters (Davies, 
1994). Evidence that neurotrophins promote growth in vivo, as well as survival, 
was finally provided by the generation of mice deficient in NGF or TrkA, which 
were then crossed with BAX deleted mice (Patel et al., 2000; Glebova & Ginty,
2004). BAX deletion prevents the death of peripheral neurons (Deckwerth et al.,
1996), facilitating study of the growth promoting effects of NGF/TrkA 
independently of their effects on neuronal survival. In these mice, DRG neurons 
extend axons through the dorsal roots and into the dorsal horn; however, 
superficial cutaneous innervation is absent suggesting a role for NGF in the 
regulation of peripheral target field innervation.
The use of ectopic sources of neurotrophins, combined with function blocking 
antibodies, has also clarified the role of these factors in the regulation of neurite 
growth (Tucker et al., 2001). In vivo gain-of-function experiments have also 
demonstrated the role of NGF in promoting neurite outgrowth from neuronal 
populations (Albers et al., 1994). A more recent study has reported the regulation 
of sympathetic development by NGF and NT-3 through TrkA, in a sequential and 
complementary manner (Kuruvilla et al., 2004). NT-3 was found to promote 
outgrowth but not survival, while NGF regulates both survival and outgrowth.
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1.4.3 Intracellular signalling pathways downstream of neurotrophic factors 
regulating neuronal survival and neurite outgrowth
The activation of Trk receptors, through interaction with neurotrophins, leads to 
the phosphorylation of several conserved cytoplasmic tyrosine residues and the 
subsequent recruitment of various intracellular signalling mediators (Huang & 
Reichardt, 2003). Phosphorylation of additional residues creates docking sites 
for adaptor proteins containing phosphotyrosine-binding domains or src- 
homology-2 motifs (Huang & Reichardt, 2001). The She adaptor protein family, 
SchA, SchB and SchC, bind specific sites in Trk receptors, activating signalling 
pathways involving the small GTPase Ras and the serine/threonine kinase Raf. 
Downstream targets include PI3K, PLC-y and MAPK family members and these 
signalling members regulate neuronal survival and growth (Patapoutian & 
Reichardt, 2001; Huang & Reichardt, 2003; Chao, 2003).
Neurotrophin signalling in the cell soma and nucleus is vital for neuronal survival 
(Atwal et al., 2000). Therefore investigations into the method of transport of 
neurotrophins from the periphery to the cell soma were conducted. NGF was 
shown to be internalised by a receptor-dependent process, which was energy 
and microtubule dependent, and transported along axons for long distances in 
small, membraneous vesicles to the cell soma (Shooter, 2001; Reichardt, 2006). 
Neurotrophins are localised within endosomes with the Trk receptors and 
activated signalling intermediates, such as PLCy (Teng et al., 2005). 
Internalisation of NGF-TrkA and retrograde transport to the soma is necessary
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for neurotrophin survival signal transmission (Rabizadeh et al., 1993; Barrett & 
Bartlett, 1994).
Two important signalling mediators, Akt and ERK, have been shown to act 
downstream of neurotrophins. Both ERK and Akt regulate the survival of 
neuronal populations (Vailliant et al., 1999). Akt promotes cell survival by 
blocking the action of pro-apoptotic proteins, such as BH3 only proteins, 
preventing binding to Bcl-2 protein members. Akt also blocks transcription factors 
FOXO and p53 thereby preventing the expression of BH-3 only proteins. Akt 
activation then prevents apoptosis by blocking the processing of pro-caspase-9, 
by the previously mentioned routes (Manning & Cantley, 2007). ERK and Akt 
have also been shown to contribute to the regulation of neurite growth in several 
neuronal populations including striatal and SCG neurons, cerebellar and 
sympathetic neurons (Gavalda et al., 2004; O’Keeffe et al., 2008; Dudek et al. 
1997; Philpott et al., 1997; Crowder & Freeman, 1998). The role of ERK in the 
regulation of NGF-induced neurite outgrowth in PC12 cells has been well 
established (Cowley et al., 1994; Markus et al., 2002) and the role of Akt and 
ERK in the regulation of neuronal survival and outgrowth will be discussed 
further in subsequent sections.
39
1.5 The receptor activator of NF-kB
1.5.1 The tumor necrosis factor superfamily
The receptor activator of NF-kB ligand (RANKL), and its associated receptor, 
RANK, are the focus of this research. These proteins are members of the tumor 
necrosis factor (TNF) superfamily and receptor superfamily, respectively. These 
families consist of over 40 members that are vital in the regulation of the immune 
system (Flehlgans & Pfeffer, 2005). TNFa, after which the family was named, 
was initially discovered as an endotoxin-induced serum factor that was able to 
cause necrosis of specific tumor cell types (Bessis et al., 2005). TNFa is now 
known as a prototypic inflammatory cytokine and has been found to be involved 
in a range of cellular processes including apoptosis, necrosis, inflammation, 
proliferation and hematopoiesis. Most TNF family members are expressed as 
type II transmembrane glycoproteins that may be cleaved by specific 
metalloproteinases to become soluble ligands, or may remain active as 
membrane bound ligands (Grivennikov et al., 2006).
TNFa was found to bind to a receptor, named TNF receptor (TNFR). A 
complementary TNFR superfamily has since been characterised and Figure 9 
shows an overview of this important family, along with their associated ligands. 
The TNF-like receptors are type I transmembrane proteins that are characterised 
by cysteine-rich domains and can be divided into three groups: those containing 
a proapoptotic domain, those lacking such a domain and decoy receptors
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(Grivennikov et al., 2006). Members of the TNF superfamily include key 
regulators of bone function such as RANKL and OPG; important regulators of 
immune function including TNFa itself, CD40L, FASL, LIGHT and many others 
(for review see Locksley et al., 2001; Hehlgans & Pfeffer, 2005).
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Fig 9: The TNF (shown in blue) and TNFR superfamilies. Arrows represent 
interactions with receptors. Ectodomains of TNFSFR members are shown in 
grey, with internal death domains as red cylinders. Adapted from Hehlgans & 
Pfeffer, 2005.
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1.5.2 TNF family members and the regulation of neuronal development
The role of TNFa in the regulation of neuronal populations is complicated. TNFa 
is upregulated during immune and inflammatory responses in the CNS (Munoz- 
Fernandez & Fresno, 1998), as well in a number of neurodegenerative diseases. 
TNFa is also found to play a role in normal neuronal development and in the 
CNS glia are a source of this cytokine with both microglia and astroglia 
producing TNFa (Mizuno et al., 2005; Munoz-Fernandez & Fresno, 1998). In 
neurons, the role of TNFa is a little more controversial. TNFa was found to 
contribute to the death of sympathetic and sensory NGF-dependent neurons 
during development, and sympathetic and sensory neurons from TNF deficient 
mice survive better than wild-type neurons (Barker et al., 2001). Cultured 
sympathetic and trigeminal neurons were also found to express TNFa and its 
receptor, TNFR, suggesting an autocrine/paracrine function for this cytokine. 
Other studies using TNFa knockout mice also suggest a function for this cytokine 
in normal, late neuronal development in neurons of the hippocampus (Golan et 
al., 2004).
The function of other TNF superfamily members in neuronal populations is also 
under investigation and recent discoveries include a role for glucocorticoid- 
induced tumor necrosis factor receptor-related protein (GITR), and its ligand, 
GITRL, in the regulation of NGF-dependent growth in neurons of the SCG 
(O’Keeffe Et al., 2008) and a role for the TNF super-family member, LIGHT 
(lymphotoxin-related inducible ligand that competes for glycoprotein D binding to
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herpesvirus entry mediator on T cells), and its receptor, herpesvirus entry 
mediator (HVEM), in the negative regulation of the growth of nodose neurons 
(Gavalda et al., 2009). To date there is no known role for the RANK, its ligand or 
decoy receptor in neuronal populations.
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1.5.3 NF-kB
One of the key downstream targets of RANK activation is NF-kB. This 
transcription factor is an important regulator of a wide variety of cellular 
processes including cell survival and proliferation, regulation of the immune 
system and responses to stress (Baldwin Jr, 1996; Karin, 1999). This 
ubiquitously expressed family of transcription factors classically consists of five 
members: p65 (RelA), RelB, c-Rel, p50 and p52 in various combinations of 
heterodimers and homodimers, of which p50/p65 is the most common. In 
unstimulated cells NF- kB is bound to members of an inhibitory family of proteins, 
the IkBs , of which there several known members (O’Neill & Kaltschmidt, 1997) 
and of these, kBa and kBp are the most common.
Activation of NF-kB involves two distinct pathways. In the canonical pathway, 
stimulation of the cell by extracellular inducers leads to kBa being 
phosphorylated on serine residues 32 and 36 by an IkB kinase (IKK) complex, 
leading to ubiquitination and proteosome mediated degradation of kBa. NF-kB is 
then free to translocate to the nucleus and bind to kB consensus sequences in 
responsive genes (Baldwin Jr, 1996; Karin, 1999). The IKK complex consists of 
three members: IKKa, IKKp and IKKy. IKKp activates NF-kB via the canonical 
pathways, whereas IKKa activates NF-kB via a non-canonical pathway involving 
phosphorylation of p100 (Senftleben et al., 2001; Xiao et al., 2006). Another 
important regulator of NF-kB is NF-kB inducing kinase (NIK). This kinase acts as
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a potent activator of members of the IKK and NF-kB families and provides a link 
between the TNFR superfamily, via the TNF-receptor associated factor (TRAF) 
family, and the NF-kB signalling pathways (Malinin et al., 1997; Regnier et al., 
1997; Woronicz et al., 1997). Traditionally, NIK phosphorylates and activates 
IKKa in the non-canonical NF-kB activation pathway (Dejardin, 2006), although 
there is evidence NIK can activate NF-kB via the canonical pathway (Zarnegar et 
al., 2008).
NF-kB has over 150 known downstream targets (Pahl, 1999). NF-kB is a target 
of many important cellular regulators and many of the biological functions of 
TNFR family members are mediated by this transcription factor (Baeuerle & 
Hentkel, 1994; Rothe et al., 1995). NF-kB has been shown to be widely 
expressed in the nervous system (O’Neill & Kaltschmidt, 1997; Bhakar et al., 
2002). NF-kB can be activated by a range of neurotransmitters and 
neurotrophins, and has been shown to regulate neuronal survival but can also 
bring about neuronal death (Kaltschmidt et al., 2005). NF-kB promotes the 
survival of several neuronal populations including cerebellar granular cells, 
cortical neurons and sympathetic and sensory neurons (Bhakar et al., 2002; 
Maggirwar et al., 1998; Middleton et al., 2000). Other functions of NF-kB in 
neuronal populations include the regulation of synaptic function, learning and 
memory and the myelination of peripheral nerves (Merlo et al., 2005; Albensi & 
Mattson, 2000; Nickols et al., 2003).
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More recently NF-kB was shown to have a role in positively regulating neurite 
outgrowth from sensory neurons of the nodose ganglia (Gutierrez et al., 2005). 
Inhibition of NF- kB was found to significantly reduce the size and complexity of 
neuritic arbours of sensory neurons cultured with BDNF during a defined period 
in development. Inhibition of NF-kB in pyramidal neurons of the CNS was also 
found to reduce the size and complexity of their dendritic arbours. Subsequently, 
NF-kB was also found to be essential for the growth promoting effects of CNTF 
in nodose neurons and CNTF was found to activate NF-kB via a non-canonical 
mechanism that involves activation of spleen tyrosine kinase and subsequent 
tyrosine phosphorylation of kBa (Gallagher et al., 2007). A subsequent study 
has shown that NF-kB negatively regulates neurite outgrowth from sympathetic 
neurons, and can also negatively regulate neurite outgrowth from sensory 
neurons depending upon the phosphorylation state of the p65 subunit (Gutierrez 
et al., 2008).
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1.5.4 RANK, RANKL and OPG
The Receptor Activator of NF-kB Ligand (RANKL) is a member of the TNF 
superfamily that plays key roles in the regulation of the immune system and bone 
homeostasis (Kearns et al., 2008). The decoy receptor of RANKL, 
Osteoprotegerin (OPG), was the first member of this vital signalling trio to be 
discovered (Simonet et al., 1998) and RANKL was subsequently cloned as a 
ligand for OPG (Lacey et al., 1998). RANKL was then cloned by three other 
independent groups as an osteoclast differentiation factor (ODF) (Yasuda et al.,
1998), a TNF-related activation-induced cytokine (TRANCE) (Wong et al., 1997), 
and as a factor necessary for T cell growth and dendritic cell function (Anderson 
et al., 1997). The name RANKL was finally accepted as standard.
RANK is a homotrimeric TNFR superfamily member initially characterized as the 
receptor for RANKL in dendritic cells before also being discovered in osteoclasts 
(Anderson et al., 1997; Li et al., 1997). RANK was cloned from a bone marrow- 
derived dendritic cell cDNA library as the receptor that mediated the survival of 
cultured dendritic cells promoted by RANKL (Anderson et al., 1997). RANK is a 
616 amino-acid protein (a.a.) with a 184 amino acid extracellular domain and a 
cytoplasmic domain of 383 amino acids (Fig 10). RANK is a key regulator of 
bone physiology and the interplay between RANK, its ligand and its decoy 
receptor determine the kinetics of bone remodeling (Kearns et al., 2008).
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RANKL is a type II transmembrane protein of 316 amino acids with a 48 amino 
acid cytoplasmic domain and an extracellular 248 amino acid domain. Murine 
RANKL shares an 85% homology with the human protein (Anderson et al.,
1997). Subsequent studies have found RANKL has three known isoforms, two of 
which are type II transmembrane ligands, the second of which is a shorter splice 
variant of the first (Ikeda et al., 2001). The third variant of RANKL lacks a 
transmembrane domain and acts a soluble form.
OPG, the decoy receptor for RANK, was the first member of the RANK trio to be 
discovered (Simonet et al., 1998) and the first found to play a role in bone 
homeostasis (Tsuda et al., 1997). OPG was initially cloned as an 
osteoclastogenesis inhibitory factor (OCIF), due to its ability to act as an inhibitor 
of the formation of osteoclasts (Yasuda et al., 1998a). OCIF was subsequently 
named OPG and molecular binding experiments demonstrated OPG binds 
RANKL and functions as a decoy receptor (Yasuda et al., 1998). OPG, is a 401 
amino acid secreted glycoprotein with similarities to TNFR-2 and CD40 (Simonet 
et al., 1997).
Since its discovery, RANK and its receptors have been found to regulate a 
number of functions in different situations. RANKL was initially characterised as 
a regulator of dendritic cell survival (Wong et al., 1997a) and subsequently, the 
binding of RANKL to its receptor was found to provide the signal to drive the 
development of osteoclasts, from haematopoietic progenitor cells (Lacey et al.,
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1998; Hsu et al., 1999). RANK was also found to play a role in the activation of 
mature osteoclasts and has been characterised as an osteoclast differentiation 
and activation factor. Figure 11 shows an illustration of the action of RANK, 
RANKL and OPG in the regulation of osteoclastogenesis.
The expression patterns of RANK, RANKL and OPG are varied. RANK is 
ubiquitously expressed in human tissue with the highest expression of RANK 
mRNA in skeletal muscle, thymus, liver, colon, small intestine, and adrenal gland 
(Anderson et al., 1997). Cell surface expression of RANK has, however, been 
reported to be limited to dendritic cells, the CD4+ T cell line MP1 and foreskin 
fibroblasts (Anderson et al., 1997), suggesting complex post-transcriptional 
control of surface protein expression. Expression of RANK receptor protein is 
also found in splenic, lymph node and bone marrow derived dendritic cells, 
activated T-cells and osteoclast progenitors (Wong et al., 1997, Yasuda et al., 
1998; Lacey et al., 1998). RANKL was found to be most highly expressed in 
thymus and lymph nodes and expression in nonlymphoid tissue is limited, and 
RANKL is abundantly found in T cells but not in B cells (Wong et al., 1997). 
RANKL is most highly expressed in spleen, bone marrow stroma and trabecular 
bone (Yasuda et al., 1998). Expression of OPG was detected in liver, lung, heart 
and kidneys as well as in the stomach, skin, and calveria and developing bone 
tissues (Simonet et al., 1997).
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Fig 10: RANK is a 616 amino acid receptor with a 383 amino acid 
cytoplasmic domain. The RANK cytoplasmic domain (unshaded) contains 
3 TRAF binding domains, which preferentially bind TRAF signalling 
mediators. Domain I preferentially binds TRAF6, while domains II and III bind 
TRAF2 and TRAF5 respectively. Adapted from Darnay et al., 1999.
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Fig 11: Mechanisms of action of OPG, RANKL and RANK in 
osteoclastogenesis. RANKL is produced by osteoblasts, which 
activates RANK on osteoblasts and preosteoclast precursors. OPG 
binds to and inactivates RANKL. RANK-RANKL interactions lead to 
osteoclast fusion, differentiation activation and survival via intracellular 
mediators including ERK, JNK, Akt and NF-?B. Adapted from Blair et 
al., 2007.
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1.5.5 RANKL, RANK and OPG knockout mice
The roles RANK, its ligand and the decoy receptor play in mammalian physiology 
have been investigated and confirmed through the generation of transgenic 
knockout animals. Mice deficient in each of the RANK signalling triumvirate have 
been generated. RANK knockout mice were generated by two independent 
groups (Dougall et al., 1999; Li et al., 2000) and were found to be highly 
osteopetrotic. Mice were also produced that over-expressed a soluble RANK-Fc 
fusion protein and these were found to be osteopetrotic due to a reduction in 
osteoclasts (Hsu et al., 1999). Recombinant RANK-Fc was found to bind to 
RANKL with high affinity in vitro suggesting a possible route of action in vivo. 
Mice lacking RANKL display severe osteopetrosis, show defects in tooth eruption 
and completely lack osteoclasts, due to an inability of osteoblasts to support 
osteoclastogenesis (Kim et al., 1998; Kong et al., 1999). RANKL deficient mice 
also lack lymph nodes and display defects in T and B lymphocyte development. 
OPG knockout mice have severe osteoporosis and very brittle bones, as well as 
increased arterial calcification (Bucay et al., 1998; Yun et al., 2001). OPG 
deficient mice were also shown to display abnormal remodeling of the otic 
capsule and progressive hearing loss (Zehnder et al., 2006).
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1.5.6 RANK signalling
The binding of RANKL to RANK activates a large number of distinct and intricate 
downstream signalling cascades and a large body of work has focused on the 
elucidation of these. Two of the first to be investigated were NF-kB and Jnk. 
Over-expression of RANK was found to be able to activate NF-kB in dendritic 
cells (Anderson et al., 1997) and in 293T cells (Darnay et al., 1998; Wong et al.,
1998) and RANK activates C-Jun N-terminal kinase (Jnk) in T Cells (Wong et al.,
1997), 293T cells (Wong et al., 1998) and in HeLa cells (Kim et al., 1999). Other 
important intracellular regulators that have been shown to be activated by RANK 
signalling include Elk-1, a MAPK substrate (Wong et al., 1998), Akt (Wong et al.,
1999) and p38 (Matsumoto et al., 2000), as well as AP-1, via other members of 
the MAPK family such as ERK (Karin, 1996). Figure 12 shows a schematic 
illustration of some of the important regulators of RANK signalling, activated 
upon the binding of RANKL to its receptor.
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Fig 12: RANK signaling pathways important in the regulation of 
osteoclastogenesis and cell survival. Adapted from Bharti & Aggarwal, 2005.
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As with other members of the TNF superfamily, the binding of RANKL to its 
receptor recruits members of the tumor necrosis factor (TNF) receptor 
associated factor (TRAF) family of intracellular messengers (Rothe et al., 1994; 
Wong et al., 1998; Kim et al., 1999; Hsu et al., 1999). RANK specifically recruits 
TRAF2, TRAF5 and TRAF6 in the regulation of its biological function (Wong et 
al., 1997a; Darnay et al., 1998; Lomaga et al., 1999) and the remaining members 
of the TRAF family, TRAF1, TRAF3 and TRAF4, have been shown not to play a 
role in regulation of TNF family member activation (Bharti & Aggarwal, 2005). 
TRAFs are characterized, in general, by a conserved C-terminal TRAF domain in 
concert with an effector N-terminal RING finger/zinc domain (Rothe et al., 1994) 
and TRAFs interact with receptors, downstream signal transducers and each 
other, through hetero- and homotypic interactions through their TRAF domains 
(Wong et al., 1998).
The TRAFs all serve distinct but similar roles in the regulation of TNFR family 
member biology. TRAF2, TRAF5 and TRAF6 have all been shown to be 
important in the regulation of NF-kB signalling; all three activate NF-kB upon 
over-expression (Rothe et al., 1995; Bishop et al., 2004; Cao et al., 1996) and all 
three have been shown to activate NF-kB through interaction with NF-kB 
inducing kinase (NIK), IkB kinase-a and -p  (Malinin et al., 1997; Regnier et al., 
1997; Song et al., 1997; Woronicz et al., 1997). TRAF2 is a key regulator of the 
activation of NF-kB by TNFa (Rothe et al., 1995), as well as playing important 
roles in the regulation of other TNF members including CD30 and CD40
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(Ansieau et al., 1996; Rothe et al., 1995), as well as Jnk (Natoli et al., 1995; 
Reinhard et al., 1997). TRAF6 has been shown to not only strongly activate NF- 
kB (Cao et al., 1996) but to be sufficient and necessary for the activation of NF- 
kB by RANK (Darnay et al., 1999). The binding of RANKL to RANK can also 
activate the serine/threonine kinase Akt through a complex involving TRAF6 and 
c-Src (Wong et al., 1999), as well as MAPK signalling members such as ERK 
(Karin, 1996) and p38 (Matsumoto et al., 2000). TRAF6 also plays a key role in 
the regulation of osteoclastogenesis and in the regulation of RANK CD40 
signalling (Wong et al., 1999a).
The binding of members of the TRAF family to RANK have been extensively 
explored and three separate studies have examined the domain that members of 
the TRAF family bind to on the RANK receptor. Darnay et al found that TRAF2, 
TRAF5 and TRAF6 bound to RANK in a region at the 85 amino acid C-terminal 
tail of the receptor and that this section was necessary for RANK mediated NF- 
kB activation, but not activation of Jnk (Darnay et al., 1997). Wong et al. also 
conducted similar experiments and found that binding sites for TRAF2 and 
TRAF5 were located at the C-terminal portion of the cytoplasmic domain (Wong 
et al., 1998) with a more membrane proximal binding site for TRAF6. In a 
subsequent study Darnay et al. found that RANK binds TRAF2, TRAF5 and 
TRAF6 at distinct locations within the C-terminal tail. TRAF2 and TRAF5 bind at 
a C-terminal site between amino acids 565-568 and 606-611, respectively, 
whereas TRAF6 binds at a more membrane proximal location between residues
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340-358 (Darnay et al., 1999). Another study found similar locations within the C- 
terminal tail necessary for the binding of TRAF family members by RANK. The 
authors also found that the TRAF6 binding site was essential for the activation of 
NF-kB and Jnk seen when over-expressing RANK in 293T cells (Hsu et al.,
1999). In general there seems to be a consensus on the location of TRAF 
binding sites within the C-terminal tail of the RANK receptor.
NF-kB is a particularly important signalling mediator of activation of RANK so the 
way in which members of the NF-kB signalling cascade are recruited by RANK 
signalling has been extensively explored. NF-kB was shown to be activated by 
RANK (Anderson et al., 1997) and mice lacking p50 and p52 are severely 
osteopetrotic (lotsova et al., 1996). Two members of the TRAF family, TRAF2 
and TRAF6, have both been shown to be required for the activation of NF- kB by 
RANK (Darnay et al., 1998) and NIK has been shown to bind both TRAF2 and 
stimulate NF-kB, acting as part of a signalling cascade connecting members of 
the TNFR superfamily to the NF-kB pathways (Malinin et al., 1997). Members of 
the IkB kinase family have also been shown to be vital for RANK signalling in the 
regulation of osteoclastogenesis and IKKa and IKKp were both found to be 
important for RANK activated NF-KB-mediated regulation of osteoclastogenesis 
(Ruocco et al., 2005). Another important NF-kB regulator is NIK. This kinase can 
interact with TRAF2 and TRAF6 in the regulation of TNF-mediated NF-kB 
activation and serves as a bifurcation point (Song, et al., 1997). NIK has also
58
been shown to be important in the regulation of the biological activity of RANK 
(Malinin et al., 1997).
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1.6 ERK
The mitogen-activated protein kinase (MAPK) family constitutes an essential and 
widespread mechanism of eukaryotic cell regulation that facilitates the responses 
of cells to a large number of different stimulations. MAPK signalling cascades 
consist of at least three protein kinases in series that lead to the activation of a 
MAP kinase (Pearson et al., 2001). These signalling cascades can be activated 
by a range of stimuli including hormones, growth factors, inflammatory cytokines 
of the TNF family and a variety of environmental stresses including radiation and 
ischemic shock (Krishna & Narang, 2008). Three MAPK families that are critical 
regulators of mammalian cell function are the extracellular regulated kinases 
(ERKs), c-Jun N-terminal kinases (Jnks) and p38. These families have been 
extensively studied and two of these, ERK and Jnk, are vital for signalling by 
RANK (Wada et al., 2006).
The first MAPKs were discovered as mitogen-stimulated tyrosine kinases 
(reviewed in Cobb et al., 1991) and the family was subsequently named mitogen- 
activated protein kinases. MAPKs are grouped into a family due to their similar 
method of activation, requiring the interaction of a three-tiered cascade. This 
consists of an MAPK, an MAPK kinase (MAPKK) and an MAPKK kinase 
(MAPKKK or MAP3K) (Krishna & Narang, 2008). MAP3Ks are Ser/Thr kinases 
that are activated by extracellular stimuli through interaction with members of the 
Ras/Rho family of small G proteins. This leads to phosphorylation and activation
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of MAPKKs and subsequent phosphorylation of threonine and tyrosine residues 
on MAPKs. MAPKs then activate downstream targets including transcription 
factors, other kinases and cytoskeletal proteins. Figure 13 shows a schematic 
diagram of MAPK signalling cascades, along with examples of downstream 
targets.
The ERKs, specifically ERK1 and ERK2, remain the most studied and best 
understood members of the MAPK family (Blenis, 2003). The fundamental roles 
of ERK1/ERK2, hereafter referred to as ERK, are in the regulation of survival, 
cell growth and proliferation in many different cells and ERK is known to be 
activated principally by mitogens and growth factors (Juntilla et al., 2008). The 
role of ERK in the regulation of neuronal populations is a more complex issue. 
ERK is involved in the regulation of diverse processes including the genesis of 
neural progenitors, learning and memory, and ERK has been widely accepted as 
a central regulator of differentiation and cell fate determination (Kawauchi et al., 
2005; Samuels et al., 2009). ERK has also been found to play a role in the 
regulation of neurite growth from different neuronal populations. ERK is a 
positive regulator and a convergence point for growth promoting signals in 
embryonic chick retinal neurons (Perron & Bixby, 1999); inhibition of ERK was 
found to inhibit the growth of cultured hippocampal neurons (Veeranna et al.,
1998), and ERK has been shown to be involved in the positive regulation of 
NGF-mediated neurite growth in SCG neurons in mice (O’Keeffe et al., 2008).
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These reports suggest an ever expanding role for ERK in the regulation of 
neuronal populations.
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Fig 13. MAPK signalling pathways. The organisation of MAPK signalling 
cascades involves three sequential kinases. Activation of upstream kinases 
leads to phosphorylation of MAPKs, which then activate downstream targets. 
Adapted from Juntilla et al., 2008.
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1.7 Akt/PI3K signalling
Another vital intracellular signal transducer is Akt or protein kinase B (PKB). PKB 
was first identified as a serine/threonine protein kinase in three separate studies 
(Jones et al., 1991; Bellacosa et al., 1991; Coffer & Woodget, 1991) and three 
isoforms of Akt have since been identified in mammalian cells: Akt-1, -2 and -3 
(Brazil & Hemmings, 2001). The other vital component in this signalling cascade, 
phosphatidylinositol 3-kinase (PI3K), was discovered in 1990 (Carpenter et al., 
1991), and Akt was found to be a downstream target of PI3K (Franke et al., 
1995; Burgering & Coffer, 1995). PI3K is composed of a p110 catalytic subunit in 
tandem with a p85 regulatory subunit and the PI3K family consists of various 
isoforms categorized into three families: I, II and III. In this thesis I am interested 
in the classical, class I subgroup. PI3K is activated in response to cytokines, 
trophic factors, growth factors and neurotrophins (Rodgers & Theibert, 2002) and 
generates phospholipids that activate Akt. PI3K phosphorylates 4,5 
phosphoinositides to generate 3,4,5 phosphoinositides in vivo (Whitman et al., 
1988) and these phosphoinositides exert their effect by recruiting effector 
proteins to intracellular membranes. Membrane-associated phosphoinositides 
interact with specific phosopholipid-binding protein domains within their effector 
proteins and Akt contains pleckstrin homology (PH) domains that bind the 
specific phosphoinositides produced by PI3K. Figure 14 shows a representation 
of the activation and recruitment of Akt by PI3K and some of the signalling 
pathways involved.
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Fig 14: Activation of PKB signaling pathways. PI3K is activated by 
upstream receptors leading to the production of phosphoinosides and the 
activation of downstream targets.in the cytoplasm and nucleus.
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The primary role Akt plays in mammalian cells is in the regulation of survival and 
the inhibition of apoptosis and, as a result, Akt has been implicated in the 
regulation of many cancer cell types (Duronio, 2008). The minimal recognition 
sequence for an Akt substrate is R-X-R-X-X-S/T-B where X represents any 
amino acid and B represents bulky hydrophobic residues and Akt has been 
found to have over 100 candidate substrates (Alessi et al., 1996; Manning & 
Cantley, 2007). The activation of Akt can influence a remarkable number of 
intracellular events that regulate the survival of mammalian cells via targets such 
as BAD, FOXO family members, IkB kinase P, and GSK-3 (Datta et al., 1999; 
Doble & Woodgett, 2003; Manning & Cantley, 2007; Cross et al., 1995). 
Although the primary role of Akt is thought to be the regulation of cell survival it 
has also been found to regulate a large number of other cellular processes 
including cell cycle progression, growth, motility and adhesion in many 
mammalian cells (Rodgers & Theibert, 2002). Akt activates the mTOR complex 
1, a critical regulator of translation initiation and ribosome biogenesis, in the 
regulation of cell growth and other important Akt substrates include GSK3, TCS2 
and PRAS40 in the regulation of cell proliferation (Manning & Cantley, 2007). Akt 
also displays an impressive level of crosstalk with other important intracellular 
pathways including NF-kB, members of the MAPK families and c-RAF.
The role of Akt in neurons is more complicated. The PI3K/Akt signalling pathway 
is known to play a role in the regulation of neuronal survival in a wide range of
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neuronal cell types (Brunet et al., 2001). This function was initially discovered in 
the NGF-mediated survival of PC12 cells (Yao & Cooper, 1995) but has since 
been confirmed in a variety of other neurons including primary cerebellar, 
sympathetic, sensory, motor cortical, hippocampal and retinal neurons (reviewed 
in Rodgers & Theibert, 2002). However, the role of Akt in sympathetic neurons is 
more controversial. Akt appears to play a key role in the regulation of survival in 
sympathetic neurons and was found to be vital for the NGF-mediated survival of 
embryonic (Crowder & Freeman, 1998) and postnatal rat sympathetic neurons 
(Philpott et al., 1997). Akt was also found to be important in the regulation of 
survival of adult sympathetic neurons (Orike et al., 2001) suggesting a key role in 
regulating the survival of sympathetic neurons throughout development and into 
adulthood. However, other studies have disagreed (Tsui-Pierchala et al., 2000; 
Kuruvilla et al., 2000) and the issue remains controversial.
PI3K/Akt has also been found to play a role in is the regulation of neurite growth 
(Rodgers & Theibert, 2002). Blocking PI3K prevents outgrowth of processes 
from a wide variety of neuronal cell types including PC12 cells, neuroblastoma 
cell lines, sensory neurons, cerebellar and motor neurons, and hippocampal 
retinal neurons (reviewed in Rodgers & Theibert, 2002). Akt is also involved in 
positively regulating growth from cultured striatal neurons (Gavalda et al., 2004). 
Akt is required for the outgrowth promoting effects of many neurontrophins 
including NGF and BDNF (Patapoutian & Reichardt, 2001).
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Hypothesis
A finding in a PCR screening for the mRNA expression of RANK indicated the 
presence of mRNA transcripts for this TNF family member in ganglia of the 
nodose, SCG and trigeminal. Other members of the TNF family have recently 
been shown to play roles in the regulation of growth and survival of these 
neuronal populations including GITR and LIGHT (O’Keeffe et al., 2008; Gavalda 
et al., 2009). NF-kB, a key downstream target of RANK, had also been shown to 
play a role in the regulation of neuronal growth in nodose and SCG populations. 
NF-kB can positively regulate the growth of nodose neurons (Gutierrez et al., 
2005) but has also been shown to negatively regulate the growth depending 
upon its phosphorylation status (Gutierrez et al., 2008). NF-kB has also been 
shown to negatively regulate the growth of SCG neurons cultured with NGF 
(Gutierrez et al., 2008).
We decided to investigate the potential role of RANK in the neurons of the 
nodose, SCG and trigeminal ganglia. A combination of antibodies directed 
against RANK and its associated family members, plasmids that express RANK 
or various deletion mutants, and RANK activating or blocking antibodies will be 
directed against neurons of the these ganglia. Known intracellular mediators of 
RANK activation will also be investigated through the use of dominant negative 
expression plasmids and pharmacological inhibitors directed against these 
signalling mediators.
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Chapter 2
Materials and Methods
2.1 Introduction
This thesis contains work performed, using various in vitro protocols, to analyse 
neuronal survival and process outgrowth in wild-type CD1 mice. Fig 16 shows an 
example experimental overview of a protocol developed in this lab, now widely 
used, in the investigation of neuronal survival and neuronal outgrowth.
2.2 Maintenance of CD1 Mice
Timed matings of CD1 mice were established to provide embryonic (E) and post­
natal (P) wild-type mice and adult mice were maintained on rodent global diet 
pellets (Harlan) and given free access to water.
2.3 Isolation of mouse embryos
Pregnant CD1 mice, at the appropriate stage of gestation, were killed by a rising 
concentration of C 02, followed by cervical dislocation in accordance with Home 
Office Regulations, as per the Home Office Animals (Scientific Procedures) Act, 
ASPA, 1986, and death was confirmed by absence of pedal reflex. Laparotomy 
was performed to isolate embryos as follows: scissors were sterilised in 70% 
alcohol, then used to make a small incision across the abdomen. The underlying 
abdominal muscles were then exposed by pulling the skin above and below the 
incision in opposite directions. An incision was then made into the anterior 
abdominal muscle, using scissors and a pair of toothed forceps to hold the 
muscle, allowing air to enter the perinatal cavity. This incision was extended
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across the abdominal muscles without the danger of cutting the intestines and 
contaminating the dissection with gut bacteria (Davies, 1995). Each gravid 
uterine horn was removed, using scissors to cut the tissue free and toothed 
forceps, and placed into a 50ml Falcon tube (Greiner) containing sterile L-15 
medium (Gibco, Invitrogen). Embryos were then placed into a 90mm Petri dish 
(Greiner), containing L15 medium, and removed from their membranes by an 
incision along the anti-mesometrial border of each uterine horn (Davies, 1995). 
Embryos were then detached from their uterine horns, removed from their 
membranes and placed into fresh L-15 medium.
2.4 Dissection of peripheral ganglia
The nodose ganglion, trigeminal ganglion and superior cervical ganglion were 
removed from mice at the appropriate age as follows. Dissections were 
performed in a laminar flow hood under standard sterile conditions and embryos 
(E18) and pups (P0-P5) were killed by decapitation by a sharp pair of scissors. A 
rising concentration of C 02 was used to kill mice older than P5 in line with ASPA 
(1986). To dissect the ganglia, the top of the skull was removed, in a plane just 
above the eyes and whisker pads. Trigeminal ganglia were identified by their 
elongated appearance and were found on the base of the skull. To locate 
nodose and SCG ganglia, heads from which the top of the skull and the forebrain 
had been removed, were cut in half along the sagittal plane. The nodose and 
SCG are found at the base of the jugular foramen by deflection of the occipital 
bone, using watchmaker’s forceps, revealing the ganglia. The nodose is attached
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to the vagus nerve at its distal aspect and is a characteristic spherical shape. 
The SCG lies along the carotid artery, attached to the sympathetic chain, and is 
a more elongated structure. All ganglia were cleaned, using tungsten needles, of 
any adherent tissue.
2.5 Preparation of tungsten needles
Two 3-5cm lengths of 0.5mm tungsten wire were bent at a 60° angle at the tips, 
and the ends placed into 1M KOH. A 3-12V AC current was passed through the 
wire and a second electrode was immersed in the solution. In this way, the end 
was gradually etched away and a taper was formed from the bend to the tip of 
the needle. A sharp tip was formed at the end, by placing the bent portion 
vertically in the solution. The needles were washed in water, and then held in 
chuck-grip platinum wire holders. Tungsten needles were sterlised before each 
use.
2.6 Dissociated neuronal cultures
2.6.1 Preparation of dishes
Culture dishes were coated with a laminin/poly-ornithin layer before seeding. 
35mm culture dishes (Greiner) were coated in 2ml 500mg/l poly-DL-ornithine 
(Sigma)/borate solution and left at ambient temperature overnight. Dishes were 
washed three times with deionized H20 and left to air dry in sterile conditions. 
50|jl HBSS (Gibco, Invitrogen) containing 0.02mg/ml laminin (Sigma) was added
72
to the centre of the dish and dishes were incubated at 37°C for 3 hours. Laminin 
was then removed before neurons were plated.
2.6.2 Culture media
Ham’s Modified F14 medium (JRH Biosciences) was prepared as 10x 
concentrated stock solution and stored at -30°C. 25ml was then added to 250 ml 
of distilled water containing 500 mg of sodium hydrogen carbonate, from which 
25ml had been removed, and penicillin (Sigma) and streptomycin (Sigma) were 
added. This 1x solution was then supplemented with 2.5ml 200mM glutamine 
(Gibco, Invitrogen) to a final concentration of 2mM. Supplemented F14 was then 
filtered using a 0.2pm filter unit (Greiner) and stored at 4°C.
2.6.3 Dissociation of ganglia
50pl 1% trypsin (Worthington) was added to 950pl HBSS (Invitrogen) and 
ganglia were added to this following dissection. This mixture was then incubated 
at 37°C for 20mins. The trypsin-HBSS mixture was removed and ganglia were 
washed twice with 10ml F12 (Gibco, Invitrogen) containing 10% heat activated 
horse serum. A fire-polished siliconised glass pipette was then used to gently 
dissociate cells to create a cell suspension (Davies, 1995).
2.6.4 Seeding of neurons
Neurons were seeded in laminin-coated 35mm dishes. 100-200 neurons were 
seeded per 12mm grid by creating a cell suspension and visualising 10pl of
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dissociated neurons, using a Nikon Diaphot inverse phase-contrast microscope, 
to estimate volume needed. These dishes were used to study neurite growth and 
neuronal survival. The appropriate volume of cell suspension was added to the 
required volume of F14 in a 50ml Falcon tube. 1ml of cell suspension was added 
to each dish, while keeping the cell suspension uniform by tipping the tube end 
over end several times. Factors were added to the dishes at the time of plating, 
or afterwards depending upon the particular experiment. Neurotrophic factors or 
pharmacological inhibitors were added to the dishes at the concentrations 
indicated in figure legends.
2.7 Estimation of neuronal survival
A standard graticule was constructed from the base of a plastic Petri dish, to 
allow quantification of neuronal survival. A scalpel blade was used to inscribe the 
base of a 900mm dish with a 12 x 12mm2 square. Cells were counted after 3 
hours in culture by mounting the graticule on an inverted phase-contrast Nikon 
Diaphot microscope. Dishes were placed on the graticule and the number of 
neurons present in the grid was then counted. Non-attached neurons were 
ignored and the number of phase bright neurons in all dishes quantified at 24 
and 48 hrs. The number of phase-bright neurons at 48 hrs, were then expressed 
as a percentage of those at 24hrs.
Transfected cells were co-transfected with a YFP-expression construct to allow 
visualisation and the number of YFP-labelled cells quantified 24 hrs and 48 hrs
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post-transfection. The number of cells surviving at 48 hrs was quantified as a 
percentage of those at 24 hrs. The area counted was defined by the presence of 
gold particles embedded in the culture dish.
2.8 Quantification of neurite outgrowth
The establishment of a functional nervous system requires the growth and 
elaboration of neural processes and Sholl analysis is a widely used method for 
quantifying neural process complexity and size in proximity to the neuronal soma 
(Gutierrez & Davies, 2007). An Axioplan Zeiss laser scanning confocal 
microscope was used to visualise and digitally acquire images for analysis. 
Transfected neurons were co-transfected with a YFP-expression construct for 
visualisation. Non-transfected cells were stained with the vital dye, Calcein-AM 
and incubated for 20 mins at 37°C before imaging. For every condition studied 
between 50 and 60 neurons were captured and neuritic arbours were traced 
using LSM510 software (Dr H Gutierrez). From these traces mean total neurite 
length and mean number of branch points were calculated. Sholl analysis was 
also carried out using these traces and for this concentric digitally generated 
rings, 30pm apart were created, centred around the cell soma and the number of 
neurites intersecting each ring was counted (Sholl, 1953). The Sholl profile, that 
is number of intersections vs. radial distance from the cell soma, was then 
plotted. Fig. 15 shows a graphic illustration of the principles of Sholl analysis.
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Fig 15: Graphic illustration of Sholl analysis. A number of concentric rings 
are centred around the neuronal soma and the number of neurites 
intersecting each ring are counted. A plot of number of intersections vs. 
distance from the soma is then generated from average data over the 
population. From Gutierrez & Davies, 2007.
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2.9 Ballistic Transfection
2.9.1 Plasmid preparation
Competent E.Coli JM109 cells were defrosted on ice. 1pl of 100|jg/ml plasmid 
DNA was added to 50pl bacteria and incubated on ice for 30 mins. Bacteria were 
heat shocked at 42°C for 90secs, placed on ice for 1min, then 950pl LB media 
(Merck) was added. Cells were incubated in a shaking incubator at 37°C with 
200rpm for 1 hr. 100pl cells in LB were then plated on LB agar (Merck) 
containing the appropriate antibiotic and incubated at 37°C overnight.
Individual colonies were selected and grown overnight in 250ml LB containing 
the appropriate selection antibiotic, at 37°C with shaking at 200rpm. Media was 
then spun, to extract the bacteria, and a high-speed plasmid maxiprep kit 
(Qiagen) was used, according to manufacturers instructions, to purify sufficient 
DNA for transfection experiments. Plasmid concentration was quantified using 
the nanodrop spectrophotometer system.
2.9.2 Preparation of gold microcarriers for ballistic transfection
Transfection of neurons was undertaken by ballistic means. Gold microcarriers 
were prepared by suspending 20mg of 1.6pm gold particles (Bio-Rad) in 10Opil of 
50mM spermidine (Sigma) and 2pg YFP expression plasmid (Clontech) together 
with 20pg of the appropriate experimental plasmid. Gold particles were 
precipitated with 100pl 2M CaCI2, washed three times with 100% ethanol,
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resuspended in 1.2ml 100% ethanol and loaded into Teflon tubing microcarriers. 
Gold particles were then thoroughly washed and stored at 4°C.
2.9.3 Ballistic transfection
Coated gold particles were shot into dissociated neurons using a hand held gene 
gun (Helios gene gun, Biorad). 35mm tissue culture dishes were prepared with a 
poly-ornithine coating, and then laminin was added to the centre of the dish. 
Neurons were plated in a 50pl drop of defined medium, following removal of the 
laminin. Neurons were given time to attach through a 3hr incubation at 37°C in a 
humidified 3.5% C 02 incubator then medium was removed before transfection. 
The coated gold particles were shot into the dissociated neurons at a pressure of 
200psi. A 70pm nylon mesh screen was placed between the gun and the cells to 
protect from the shock wave. Following transfection, 2ml of F14, with the 
appropriate neurotrophic factor, was added to the dish and cells were returned to 
the incubator.
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Fig 16: Experimental Outline. Flow chart describing the basic 
experimental design. (A) Ganglia are extracted from wild-type mice and 
plated in defined media (B). Neurons are transfected by ballistic means 
or pharmacological factors are added, together with neurotrophic factors 
(C). Neurons are counted after 24 hours and images taken for 
quantification of neuritic outgrowth (D) and surviving neurons counted 
again at 48 hours post transfection to allow calculation of percentage 
survival.
2.10 Pharmacological inhibitors
Pharmacological inhibitors of ERK, U0126 (Calbiochem) and PD98059 
(Calbiochem), and Akt, LY294002 (Biomol Research Laboratories) and 
wortmannin (Calbiochem), were prepared to required concentration in DMSO. 
Stocks were maintained at -20°C.
2.11 Immunohistochemistry
Neurons were plated in 35mm culture dishes and fixed in ice-cold methanol. 
Cultures were washed with PBS, then blocked with 5% BSA in PBS. Cells were 
incubated overnight with primary antibodies in 1% BSA at 4°C. We used 
antibody to p-tubulin (1:1000, Promega), RANK (1:1000, R& D Systems), 
RANKL (1:500, R&D Systems) and OPG (1:1000, Sigma). After washing, cells 
were incubated with the appropriate secondary antibody (1:500, Alexa-Fluor, 
Invitrogen) for 1 hr at room temperature and were counterstained with DAPI 
(Invitrogen; 50ng/ml). Additional cultures were established and screened using 
only the secondary antibody to test the efficacy of secondary antibody binding.
2.12 Western blots
P0 nodose ganglia were dissected and dissociated according to previous 
sections (2.4 and 2.6.3 respectively). Neurons were plated at high density in 
poly-ornithine/laminin coated 96-well plates (Greiner), with around 5,000 neurons 
per well, in defined medium. 10ng/ml BDNF was added to the wells for the
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indicated time, two hours after plating. Following removal of the medium, RIPA 
buffer (50mM Tris pH7.4, 150mM NaCI, 10% glycerol, 1% Triton-X, 1mM EDTA 
and 100pg/ml PMSF) was added to lyse the cells. Centrifugation at greater than 
10,000g and at 4°C was used to remove insoluble debris and the supernatant 
was stored at -80°C.
Protein extracts were analysed by sodium-dodecyl sulfate (SDS) polyacrylamide 
gel followed by western blotting as per Laemmli (1970) with modifications. A 10% 
polyacrylamide separating mini-gel was used with a 5% stacking gel (Bio-Rad, 
mini-PROTEAN® 3 Cell). Equal amounts of each sample and sample buffer, 
were mixed in an eppendorf tube and boiled for 5 min before being loaded in the 
gel. Biotinylated molecular weight markers were loaded onto the gels to confirm 
molecular weight. The gel was assembled and run for 20 min at 80V, then 45 
min at 140V. Proteins were then transferred to polyvinyl-difluoride (PVDF) 
membranes (Amersham) using the Bio-Rad trans-blot system. Transfer was 
carried out in transfer buffer according to manufacturers protocol, for 1 hr at 
100 V.
Membranes were then blocked for 1 hr using 5% dried milk in PBS with 1% 
Tween-20 (PBS-T) at room temperature with gentle agitation. Following this 
membranes were washed twice in PBS before being incubated with 1° 
antibodies at 4°C overnight. Antibodies for phospho-ERK1/2 (Thr202/Tyr204, 
1:1000, Cell Signalling), total ERK (1:1000, Cell Signalling), phospho-Akt
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(1:1000, Cell Signalling) and Akt (1:1000, Cell Signalling) or p-Tubulin 
(Promega; 1:1000) were diluted in 1% dried milk with 5% BSA and 0.002% 
sodium azide. Membranes were washed twice for 10 min in PBS-T and then 
incubated in the appropriate peroxidase linked secondary antibody (Amersham) 
in 1% BSA in PBS-T at room temperature for 1 hr with gentle agitation. ECL-plus 
(Amersham) was used to visualise stainings according to manufacturers 
instructions. ECL-plus was applied to the blot for 1 min, then drained from the 
membrane. The membrane was sandwiched between two sheets of acetate, 
placed in an autoradiography cassette and exposed to Hyperfilm (Amersham). 
The film was developed and fixed manually (Kodak GBX developing and fixing 
solution, Sigma). After visualisation of the antibody complexes, the blot was 
stripped of primary antibodies and incubated in mouse anti-p-tubulin (1:10,000, 
Chemicon) in 1% BSA in PBS-T for 1 hr at room temperature. Following 
washing, as decribed above, visualisation of the antibody complexes was carried 
out as above.
2.13 Statistical analyses
Data are presented as means ± SEM, and pair-wise statistical significance 
comparison was determined by Student’s t test. Multiple comparisons were 
made by one-way analysis of variance (ANOVA) followed by Fisher’s post hoc 
test. Accepted level of significance was P<0.05. For neurite growth analysis 
between 50 and 60 neurons were sampled per condition and each experiment 
was repeated three times.
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Chapter 3
RANK is a novel regulator of neurite growth in the developing peripheral
nervous system
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3.1 Introduction
A large number of locally acting and diffusible signalling molecules regulate the 
growth and guidance of axons to their targets and the terminal arborization within 
these targets. A wide variety of cells provide these molecules, both en route to 
and within their finals targets, and these molecules bind to receptors on the 
advancing axons to influence growth rate, branching and direction (Chilton, 
2006; Zhou & Snider, 2006). Neurotrophic factors, such as members of the 
neurotrophin family, GDNF and gp130 cytokine families which regulate neuronal 
survival, also influence the growth and morphology of neural processes (Davies 
et al., 2003). Several members of the TNF superfamily have recently been 
implicated in the regulation of the growth of sensory and sympathetic neurites. 
GITR, and its ligand, GITRL, have been found to be essential for the NGF- 
dependent growth of axons and, consequently, innervation of targets in neurons 
of the SCG (O’Keeffe et al., 2008) and the TNF member LIGHT is a negative 
regulator of neurite growth in the sensory neurons of the nodose ganglia 
(Gavalda et al., 2009).
The TNF superfamily constitutes 19 members that are critical in the regulation 
and maintenance of the immune system (Hehlgans & Pfeffer, 2005). 
Increasingly, the role of this superfamily in other tissues and organs is also being 
recognized. TNFa was the first member of this family to be discovered (Carswell 
et al., 1975) and in the CNS this cytokine is upregulated during immune and
84
inflammatory responses and in a number of neurodegenerative diseases 
(Munoz-Fernandez & Fresno, 1998). TNFa also plays a role in facilitating 
naturally occurring neuronal death in developing sympathetic and sensory 
ganglia (Barker et al., 2001). Members of the TNF superfamily are expressed as 
type II transmembrane glycoproteins that bind a complementary receptor 
superfamily of type I transmembrane proteins (Flehlgans & Pfeffer, 2005).
RANK is a member of the TNFR superfamily that, together with its ligand, 
RANKL, and a decoy receptor, OPG, plays an essential role in the regulation of 
osteoclast differentiation, activity and survival (Bharti & Aggarwal, 2004). RANKL 
binding to its receptor induces haematopoietic progenitor cells to differentiate 
into osteoclasts, as well as activating mature osteoclasts (Wada et al., 2006) and 
OPG inhibits bone turnover by preventing RANK-RANKL binding. RANK is also 
known to play vital roles in the regulation of the immune system (Kearns et al., 
2008) and in the regulation of dendritic cell survival (Wong et al., 1997). To date, 
there is no known expression or role for the RANK signalling system in the 
nervous system.
A finding in a PCR screen for the expression of members of the TNFR 
superfamily in developing sympathetic and sensory ganglia that RANK mRNA is 
expressed in the SCG, trigeminal and nodose ganglia of fetal and postnatal mice 
was the starting point for the studies reported here. Detailed real-time PCR 
analysis revealed the developmental time-course of expression of RANK mRNA
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in these ganglia and immunocytochemistry localized RANK, RANKL and OPG to 
the neurons of these ganglia. Over-expression of RANK was found to inhibit 
neurotrophic factor-promoted neurite growth from the neurons without affecting 
their survival, suggesting that RANK signalling is a selective negative inhibitor of 
neurite growth from developing sensory and sympathetic neurons.
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Results
3.2 RANK, RANKL and OPG are expressed in nodose, SCG and trigeminal 
neurons of developing mice
A PCR screen carried out in the laboratory for the expression of members of the 
TNFR superfamily in sympathetic and sensory ganglia of developing mouse 
embryos and neonates revealed that RANK mRNA is expressed in the SCG, 
trigeminal and nodose ganglia of fetal and postnatal mice (data not shown; Dr 
Gerard O’Keeffe). To establish which cells in the nodose ganglion express 
RANK, and to determine if RANKL and OPG are also expressed, specific 
antibodies were used to localize these proteins in PO dissociated nodose neuron 
cultures. In addition to antibodies against either RANK, RANKL or OPG, nodose 
neurons were also probed with antibodies against the pan-neuronal marker (3-111 
tubulin and cell nuclei were labeled with the fluorescent marker DAPI.
The cell bodies of all PO nodose neurons examined were found to express 
RANK, RANKL and OPG (Fig. 17). In contrast, non-neuronal cells showed little 
or no immunoreactivity for any of these proteins (data not shown). A similar 
approach was used to determine which cells within PO SCG and trigeminal 
ganglia expressed RANK, RANKL and OPG. In a similar manner to nodose 
neurons, PO SCG and trigeminal neurons (Figs. 18 and 19, respectively) 
expressed all three proteins within their cell soma, but not within the neuronal
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processes, whereas non-neuronal cells did not express detectable levels of the 
proteins (data not shown).
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Figure 17: RANK, RANKL and OPG expression in developing nodose neurons. (A)
Photomicrographs of the same fields of PO dissociated cultures triple labelled for RANK, B-lll 
tubulin and DAPI. (B, C) A neuron labelled for either RANKL or OPG, respectively. Scale 
bars=50pm.
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Figure 18: RANK, RANKL and OPG expression in developing SCG neurons. (A)
Photomicrographs of the same fields of PO SCG dissociated cultures triple labelled for RANK, 
B-Tubulin and DAPI. (B, C) A neuron labelled for either RANKL or OPG, respectively. Scale 
bars=50pm
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Figure 19: RANK, RANKL and OPG expression in developing trigeminal neurons.
Photomicrographs of PO trigeminal dissociated cultures labelled for (A) RANK, (B) RANKL and 
(C) OPG. Scale bars=50|jm
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3.3 Over-expression of RANK reduces the extent of neurite growth from PO 
nodose neurons cultured with either BDNF or CNTF
Because NF-kB signalling has been shown to play a role in regulating the growth 
and branching of neurite from developing nodose neurons (Gutierrez et al., 2005; 
Gutierrez et al., 2008; Gavalda et al., 2009) and because RANK is known to 
activate NF-kB (Wada et al., 2006), it was hypothesized that RANK may play a 
role in regulating neurite outgrowth from these neurons through modulating the 
action of NF-kB. To investigate this possibility, P0 nodose neurons were plated 
at high density in culture medium supplemented with 10ng/ml BDNF and co­
transfected with a YFP expression construct, together with either a RANK 
expression construct to enhance RANK signalling by over-expression or an 
empty control plasmid. Fluorescent neurons were counted at 24 and 48 hours 
after plating to allow calculation of percentage survival. Over-expression of 
RANK was found to have no effect on the survival of P0 nodose neurons (Fig. 
20A). The complexity of neuronal arbors was quantified 24 hours after plating, by 
imaging followed by Sholl analysis. Sholl analysis provides a graphic illustration 
of neurite length and branching with distance from the cell body (Gutierrez et al., 
2007). RANK over-expression, but not the control plasmid, significantly 
decreased neurite growth from nodose neurons cultured in BDNF supplemented 
medium (Fig. 20). Over-expressing RANK reduced the mean extent of neurite 
growth from nodose neurons by 75%, as reflected in a downward shift in the 
Sholl profile (Fig. 20B), and significant decreases in the mean total length of
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neurites (Fig. 20C) and the mean number of branch points (Fig. 20D). Figure 24 
shows the typical appearance of nodose neurons transfected with the RANK 
expression construct compared to control-transfected cells.
The growth and survival of developing nodose ganglion neurons can be 
sustained by either BDNF or CNTF (Davies et al, 1993; Horton et al., 1998). To 
determine if the neurite growth inhibitory effect of RANK over-expression is 
specific for BDNF-promoted neurite growth or whether this also affects CNTF- 
promoted growth, the effect of over-expressing RANK on the extent of neurite 
outgrowth from nodose neurons supported by CNTF was also investigated. PO 
nodose neurons were plated for 3 hours then co-transfected with a YFP 
expression plasmid together with either a RANK expression construct or an 
empty vector and cultured in medium containing CNTF (50ng/ml). Neurons were 
counted at 24 and 48 hours after plating, to calculate percentage survival and 
over-expressing RANK was found to have no effect on the survival of PO nodose 
neurons cultured with CNTF (Fig. 21 A). Neurons were imaged after 24 hours in 
culture for analysis of neurite growth. The over-expression of RANK significantly 
reduced the mean total length of PO nodose neurons cultured with CNTF (Fig. 
21C). Over-expression of RANK also reduced the mean number of branch points 
(Fig. 21D) and shifted the Sholl profile downwards (Fig. 21B). The decrease in 
growth was similar in magnitude to the effect found when over-expressing RANK 
in PO nodose neurons cultured in medium containing BDNF (Fig. 20). Figure 24
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shows the typical appearance of nodose neurons transfected with the RANK 
expression construct and cultured with CNTF.
3.4 Over-expression of RANK reduces neurite growth from PO SCG and 
trigeminal neurons cultured with NGF
Because NF-kB is also known to play a role in regulating neurite growth from the 
sympathetic neurons of the SCG (Gutierrez et al., 2008) and because RANK 
mRNA was found to be expressed in the SCG (data not shown) I decided to 
investigate whether RANK signalling is able to regulate neurite outgrowth from 
this neuronal population.
Dissociated PO SCG neurons were plated for 3 hours in medium containing 
10ng/ml NGF and then transfected with a YFP expression construct together 
with either a RANK expression construct or an empty control vector. Fluorescent 
neurons were counted at 24 and 48 hours to calculate the percentage of 
transfected neurons surviving at 48 hrs compared to 24 hrs. Over-expressing 
RANK was found to have no effect on the survival of PO SCG neurons cultured 
with NGF (Fig. 22A). Neurons were imaged at 24 hours for Sholl analysis of 
neurite growth. Over-expressing RANK was found to significantly decrease 
neurite growth from PO SCG neurons, compared to control transfected neurons, 
as reflected by a downward shift in the Sholl profile (Fig. 22B) as well as a 
decrease in mean total neurite length total length (Fig. 22C) and the mean 
number of branch points (Fig. 22D). The effect of over-expressing RANK on
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reducing neurite outgrowth from PO SCG neurons cultured with NGF was less 
than the effect of over-expressing RANK in PO nodose neurons cultured with 
either BDNF or CNTF. In the case of PO SCG neurons exogenous RANK 
expression decreased mean total neurite length and the mean number of branch 
points by approximately 50%, whereas over-expressing RANK reduced those 
parameters in PO nodose neurons by approximately 75%. Figure 24 shows the 
typical appearance of RANK transfected PO SCG neurons supplemented with 
NGF and the relavant controls.
To investigate whether over-expressing RANK reduced neurite outgrowth from 
trigeminal sensory neurons, neurons were co-transfected ballistically, 3 hours 
after plating, with a YFP-expression construct in concert with either a RANK 
expression plasmid or an empty control vector and then cultured in media 
supplemented with NGF (10ng/ml). Fluorescent neurons were counted after 24 
and 48 hours in culture to allow the percentage survival at 48 hrs to be 
calculated. Over-expressing RANK did not effect the survival of PO trigeminal 
neurons (Fig. 23A). However, over-expression of RANK significantly reduced 
neurite outgrowth, as shown by a downward shift in the Sholl profile (Fig. 23B), a 
significant decrease in mean total neurite length (Fig. 23C) and a significant 
decrease in the mean number of branching points (Fig. 23D). Like SCG neurons, 
neurite outgrowth from PO trigeminal neurons was less affected by RANK over­
expression than neurite outgrowth from PO nodose neuron. Figure 24 shows the
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typical appearance of RANK transfected PO trigeminal neurons supplemented 
with NGF and the relative controls.
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Figure 20: Effect of over-expressing RANK on BDNF-dependent growth from P0 nodose 
neurons. P0 nodose neurons were co-transfected 3 hours after plating with a YFP expression 
construct together with either a RANK expression construct or an empty vector and cultured with 
BDNF (10ng/ml). Percentage survival after 48 hours (A). Sholl analysis (B), total neurite length 
(C) and number of branch points (D). The results are derived from the grouped data of 50-70 
neurons and very similar data were obtained in three independent experiments. Statistical 
comparison are with respect to control-transfected neurons (***p<0.001, ANOVA with Fisher’s 
post hoc).
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Figure 21: Effect of over expressing RANK on CNTF-dependent growth from P0 nodose 
neurons. P0 nodose neurons were co-transfected 3 hours after plating with a YFP expression 
construct together with either a RANK expression construct or an empty vector and cultured with 
CNTF (50ng/ml). Percentage survival after 48 hours (A). Sholl analysis (B), total neurite length 
(C) and number of branching points (D). The results are derived from the grouped data of 50-70 
neurons and very similar data were obtained in three independent experiments. Statistical 
comparison are with respect to control-transfected neurons (***p<0.001 , ANOVA with Fisher’s 
post hoc).
98
B80
70
60
_  50 (0 >
t  40
30
20
10
|  Control 
Q  RANK
u
<5 r> 
E
8
Control 
-O  RANK
7
6
5
4
2
1
0
50 150 250 350 450 550
Distance from Soma ((jm)
1800
1600
o> 1400 
c
.3 1200
•5 1000
£  800
ca
o 600
c6 400 a>
2  200
S 8
o 6
§ 4
to p
Control
RANK
|  Control 
[ ]  RANK
Figure 22: Effect of over expressing RANK on NGF-dependent growth from P0 SCG 
neurons. P0 SCG neurons were transfected 3 hours after plating with a YFP expression 
construct together with either a RANK expression construct or an empty vector and cultured with 
NGF (10ng/ml). Percentage survival after 48 hours (A). Sholl analysis (B), total neurite length (C) 
and number of branching points (D). The results are derived from the grouped data of 50-70 
neurons and very similar data were obtained in three independent experiments. Statistical 
comparison are with respect to control-transfected neurons (***p<0.001 , ANOVA with Fisher’s 
post hoc).
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Figure 23: Effect of over expressing RANK on NGF-dependent growth from PO trigeminal 
neurons. P0 trigeminal neurons were co-transfected 3 hours after plating with a YFP expression 
construct together with either a RANK expression construct or an empty vector and cultured with 
NGF (10ng/ml). Percentage survival after 24 hours (A). Sholl analysis (B), total neurite length (C) 
and number of branching points (D). The results are derived from the grouped data of 50-70 
neurons and very similar data were obtained in three independent experiments. Statistical 
comparison are with respect to control-transfected neurons (***p<0.001, ANOVA with Fisher’s 
post hoc).
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Figure 24: Effect of over-expressing RANK in different neuronal populations.
Photomicrographs of typical neurons tranfected with the RANK expression construct 
(RANK) or a  control vector (Control) and incubated in the appropriate neurotrophin or 
cytokine. (A) Nodose neuron with BDNF, (B) Nodose neuron with CNTF (50ng/ml), (C) 
S C G  neuron with NG F, (D) trigeminal neuron with NGF. Scale bar = 50pm.
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3.5 Over-expression of RANK in nodose, SCG and trigeminal neurons 
reduces the growth of these neuronal populations across a range of 
developmental timepoints
To ascertain if the inhibitory effect of RANK over-expression on BDNF-promoted 
neurite growth occurs over a particular stage of development, cultures were 
established from nodose ganglia at a range of embryonic and postnatal stages. 
E18, PO, P5 and P10 nodose neurons were co-transfected 3 hours after plating 
with a YFP expression plasmid and either the RANK expression construct or an 
empty control vector, then incubated for 48 hrs in media containing BDNF 
(10ng/ml). The percentage neuronal survival was determined by counting the 
number of fluorescent transfected neurons at 24 and 48 hours post transfection 
and images were captured at 24 hours post transfection for analysis of neurite 
growth. Over-expression of RANK did not affect the survival of nodose neurons 
relative to controls at any age studied (Fig. 26A). Sholl analysis demonstrated 
that over-expression of RANK decreased the extent of neurite outgrowth from 
nodose neurons, relative to controls, at every stage investigated (Fig. 25A-D) 
from E18 to P10 with the effect increasing from earlier to later timepoints. Mean 
number of branch points (Fig. 26B) and mean total neurite length (Fig. 26C) were 
also significantly reduced compared to controls at each age investigated.
Similar analysis of the effects of RANK over-expression on NGF-promoted 
neurite growth from SCG neurons and trigeminal neurons of different 
developmental ages revealed that exogenous RANK expression does not affect
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the survival of SCG and trigeminal neurons cultured with NGF at either E18, PO, 
P5 or P10 (Figs. 28A and 30A). Over-expression of RANK, however, significantly 
reduced neurite outgrowth from SCG and trigeminal neurons at all these ages, 
as revealed by Sholl analysis (Figs. 27A-D and 29A-D), mean total neurite length 
(Figs 28C and 30C) and branch point number (Figs 28B and 30B). The effect of 
over-expressing RANK on neurite growth from SCG neurons increased at later 
timepoints, in similar fashion to results in the nodose (Fig. 25). However, the 
effect of over-expression of RANK on NGF promoted neurite growth from 
trigeminal neurons was comparable at all ages examined.
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Figure 25: Over-expressing RANK reduces neurite growth from nodose neurons at 
different developmental stages. E18, P0, P5 and P10 nodose neurons were co-transfected 3 
hours after plating with a YFP expression construct together with either a RANK expression 
construct or an empty vector and cultured with BDNF (10ng/ml). (A-D) Sholl analysis of neurite 
arbour morphology 24hr after transfection of E18, P0, P5 and P10 nodose neurons respectively. 
The results are derived from the grouped data of 50-70 neurons and very similar data were 
obtained in three independent experiments.
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Figure 26: Over-expressing RANK reduces neurite growth from nodose neurons at 
different developmental stages without affecting survival. E18, PO, P5 and P10 nodose 
neurons were co-transfected 3 hours after plating with a YFP expression construct together with 
either a RANK expression construct or an empty vector and cultured with BDNF (10ng/ml). (A) 
survival at 48 hours (B) Total neurite length (C) Number of branch points of E18, PO, P5 and P10 
nodose neurons. Data have been normalised to 100% for controls to facilitate comparison of 
effects at different ages. The results are derived from the grouped data of 50-70 neurons and 
very similar data were obtained in three independent experiments. Statistical comparison are 
with respect to control-transfected neurons (*p<0.05, ***p<0.001 , ANOVA with Fisher’s post 
hoc).
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Figure 27: Over-expressing RANK reduces neurite growth from SCG neurons at different 
developmental stages. E18, P0, P5 and P10 SCG neurons were co-transfected 3 hours after 
plating with a YFP expression construct together with either a RANK expression construct or an 
empty vector and cultured with NGF (10ng/ml). (A-D) Sholl analysis of neurite arbour 
morphology 24hr after transfection of E18, P0, P5 and P10 SCG neurons respectively. The 
results are derived from the grouped data of 50-70 neurons and very similar data were obtained 
in three independent experiments.
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Figure 28: Over-expressing RANK reduces neurite growth from SCG neurons at different 
developmental stages without affecting survival. E18, PO, P5 and P10 SCG neurons were 
co-transfected 3 hours after plating with a YFP expression construct together with either a RANK 
expression construct or an empty vector and cultured with BDNF (10ng/ml). (A) survival at 48 
hours (B) Total neurite length (C) Number of branch points of E18, PO, P5 and P10 SCG 
neurons. Data have been normalised to 100% for controls to facilitate comparison of effects at 
different ages. The results are derived from the grouped data of 50-70 neurons and very similar 
data were obtained in three independent experiments. Statistical comparison are with respect to 
control-transfected neurons (***p<0.001 , ANOVA with Fisher’s post hoc).
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Figure 29: Over-expressing RANK reduces neurite growth from trigeminal neurons at 
different developmental stages. E18, P0, P5 and P10 trigeminal neurons were co-transfected 
3 hours after plating with a YFP expression construct together with either a RANK expression 
construct or an empty vector and cultured with NGF (10ng/ml). (A-D) Sholl analysis of neurite 
arbour morphology 24hr after transfection of E18, P0, P5 and P10 trigeminal neurons 
respectively. The results are derived from the grouped data of 50-70 neurons and very similar 
data were obtained in three independent experiments.
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Figure 30: Over-expressing RANK reduces neurite growth from trigeminal neurons at 
different developmental stages without affecting survival. E18, P0, P5 and P10 trigeminal 
neurons were co-transfected 3 hours after plating with a YFP expression construct together with 
either a RANK expression construct or an empty vector and cultured with NGF (10ng/ml). (A) 
survival at 48 hours (B) Total neurite length (C) Number of branch points of E18, PO, P5 and P10 
trigeminal neurons. Data have been normalised to 100% for controls to facilitate comparison of 
effects at different ages. The results are derived from the grouped data of 50-70 neurons and 
very similar data were obtained in three independent experiments. Statistical comparison are 
with respect to control-transfected neurons (***p<0.001 , ANOVA with Fisher’s post hoc).
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Figure 31: Summary of results. RANK, RANKL and OPG are detectable in neurons of 
the nodose, SCG and trigeminal and RANK OE decreases growth from these neurons 
across a range of ages.
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3.6 Discussion
I have discovered that RANK, a member of the TNFR superfamily with no 
previously described function in the nervous system, is a potent negative 
regulator of neurite growth from developing sensory and sympathetic neurons. 
RANK mRNA expression significantly increased from early embryonic ages to 
early postnatal ages in nodose, SCG and trigeminal ganglia and RANK, RANKL 
and OPG were localized to neuronal cells in dissociated cultures established 
from nodose, SCG and trigeminal ganglia from PO mice. These TNF and TNFR 
superfamily members were present in the neurons of each population examined, 
but were absent in the non-neuronal cells of the ganglia, during the period of 
development when the neurons are extending and refining their connections in 
their respective target fields.
Over-expression of RANK in cultured nodose, SCG and trigeminal neurons 
markedly inhibited the neurite-growth promoting effects of the appropriate growth 
factor, without affecting survival. In each instance the over-expression of RANK 
was found to significantly decrease the neuritic outgrowth from these neurons 
compared with control transfected neurons. Another member of the TNFR 
superfamily has also recently been found to play a role in the negative regulation 
of neurite outgrowth from sensory neurons. HVEM and its ligand, LIGHT, was 
found to inhibit BDNF-promoted neurite growth in nodose neurons (Gavalda et 
al., 2009). Additional experiments, using antibodies directed against RANK,
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could have been used to confirm overexpression of this TNF family member by 
transfection of the expression construct.
Immunohistochemistry demonstrated that RANK and RANKL are expressed in 
neurons of nodose, SCG and trigeminal ganglia. All neurons examined were 
found to express both proteins suggesting they are co-expressed and that 
RANK-RANKL signalling may operate in either an autocrine manner within 
individual neurons or by a paracrine route between neurons. The basal level of 
RANK-RANKL signalling may play a role in restricting the neurite outgrowth from 
neurons that are unsuccessful in competition for in vivo target derived 
neurotrophic support. The presence of OPG also raises the possibility that this 
decoy plays a role in regulating the growth from these neuronal populations, 
through its interactions with RANKL. Although immunohistochemistry revealed 
the presence of RANK and its associated family members, in neurons of the 
nodose, SCG and trigeminal, additional controls to verify the efficacy of these 
antibodies on cells known to express RANK, such as dendritic cells (Anderson et 
al., 1997) would have been useful.
RANK over-expression results in a similar reduction in neurite growth from 3 
distinct neuronal populations, without affecting the survival of these neurons. 
Previous studies have demonstrated that over-expression of RANK activates NF- 
kB (Anderson et al., 1997; Darnay et al., 1997) as was found to be the case in 
nodose neurons (data not shown; Dr H Gutierrez, personal communication). The
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effect of over-expressing RANK occurs when these neurons are supported by 
neurotrophins, as well as a cytokine and these findings raise the possibility that 
RANK signalling plays an important role in the regulation of neurite outgrowth 
from different populations of PNS neurons. Studies of sensory and sympathetic 
innervation density in RANK knockout mice (Dougall et al., 1999; Li et al., 2000) 
will further our understanding of the role of this receptor in neurotrophin- 
mediated growth in these neuronal populations. Further experiments, using 
siRNAs directed against RANK, RANKL and OPG, as well as transfection of 
neurons with RANKL and OPG expression plasmids, would be useful in 
increasing our understanding of the role that RANK signalling plays in the 
regulation of neurite growth from nodose, SCG and trigeminal neurons.
In addition to exogenous expression of RANK, sensory and sympathetic neurons 
were incubated with a variety of factors, including a RANK agonist, a soluble 
RANKL and a RANK blocking antibody, at a range of concentrations, to explore 
the role of RANK in the regulation of neuronal survival and growth. None of these 
factors provided a consistent effect on the growth or survival of nodose or SCG 
neurons cultured with BDNF or NGF respectively, possibly due to the inefficacy 
of commercially available ligands, or possibly due to the presence of OPG in 
neurons of sensory and sympathetic populations. Control experiments designed 
to test the efficacy of these antibodies against cell lines with a known response, 
such as dendritic cells (Anderson et al., 1997), are required. Additional 
experiments over-expressing RANKL in nodose neurons also displayed a similar
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reduction in size of neuritic arbours when cultured in BDNF (data not shown; Dr 
H Gutierrez, personal communication), providing further evidence for the role of 
RANK and its ligand, in the regulation of neurotrophin-mediated growth.
Neuronal development within the sensory and sympathetic nervous systems is 
subject to stringent spatial and temporal regulation. To ascertain whether the 
inhibitory effect of over-expressing RANK on neurite growth occurs over a 
particular period of development, RANK was over-expressed in cultures 
established from sensory and sympathetic ganglia over a range of ages from 
E18 to P10. In each instance, a significant reduction was seen in the growth of 
neurites, compared to control transfected cells, with the magnitude of the effect 
increasing at later time points for nodose and SCG neurons. Other TNF family 
members, such as GITR (O’Keeffe et al., 2008) and LIGHT (Gavalda et al., 
2009), have been found to have similar developmental “windows”. GITR 
regulates NGF-promoted growth of SCG neurons at P1 and P3, but not at E18 or 
P5. LIGHT displays a similar pattern with over-expression of LIGHT decreasing 
the growth of nodose neurons at E18 and P0, but not at E16 or P3. NF-kB, a key 
regulator of RANK activation, was found to positively regulate the growth of 
processes of nodose neurons in a distinct period of development between E18 
and P1 with maximal effect at P0 (Gutierrez et al., 2005). Thus the decrease in 
growth seen when over-expressing RANK, across a wide range of ages, is 
surprising and further experiments at earlier and later timepoints are warranted 
to expand the role of RANK in the regulation of the growth of sensory and
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sympathetic neuronal populations. Experiments using conditional RANK 
knockout mice are necessary to confirm that RANK negatively regulates neurite 
growth across a range of ages in sensory and sympathetic neuronal populations. 
Figure 32 displays an overview of the results contained within this chapter.
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Chapter 4
RANK signalling regulating neurite outgrowth from PO nodose neurons.
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4.1 Introduction
In Chapter 3 I demonstrated that RANK, RANKL and the decoy receptor, OPG, 
are all expressed in neurons of neonatal nodose, SCG and trigeminal ganglia 
(Figs. 17-19) and that over-expression of RANK decreases the extent of 
neurotrophin-promoted growth from these neurons without affecting survival 
(Figs. 20-23). Here, I report studies carried out on nodose neurons to ascertain 
which intracellular signalling proteins mediate the neurite growth-inhibitory effect 
of RANK over-expression.
Previous research has demonstrated that a large number of distinct signalling 
pathways can transduce RANK activation into defined biological outcomes. Two 
of the most important of these are the NF-kB and JNK signalling pathways 
(Wada et al., 2006) which RANK activates in a variety of cell types (Anderson et 
al., 1997; Darnay et al., 1998; Wong et al., 1997; Wong et al., 1998; Kim et al., 
1999). Other important targets of activated RANK include AP-1 via ERK (Karin, 
1996), Akt (Wong et al., 1999) and members of the MAPK family, such as p38 
(Matsumoto et al., 2000).
As with other members of the TNF receptor superfamily, RANK activates 
downstream signalling pathways through interactions with members of the TRAF 
family (Rothe et al., 1994; Wong et al., 1998; Kim et al., 1999; Hsu et al., 1999). 
This family consists of six members, TRAFs 1-6, though only TRAF2, TRAF5
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and TRAF6 are involved with downstream activation of NF-kB and JNK (Bharti & 
Aggarwal, 2004). TRAF2 and TRAF6 appear to be essential for RANK induced 
activation of NF-kB (Darnay et al., 1999), and TRAF2 and TRAF6 interact with 
vital NF-kB signalling mediators, including NIK, IKKa and IKK(3 (Malinin et al., 
1997; Regnier et al., 1997; Song et al., 1997; Woronicz et al., 1997). The TRAFs 
also activate JNK and p38 through their amino-terminal RING-zinc finger domain 
(Darnay et al, 1999, Baud et al., 1999).
RANK has been shown to bind TRAF2, TRAF5 and TRAF6 at distinct locations 
within its cytoplasmic domain (Darnay et al., 1998; Wong et al., 1998; Hsu et al., 
1999). RANK binds TRAF2 and TRAF5 at the C-terminal end of the cytoplasmic 
tail between amino acid residues 565-568 and 606-611, respectively. RANK 
binds TRAF6 at a site more proximal to the membrane, between residues 340- 
358 (Darnay et al., 1999), and the TRAF6 binding site was found to be sufficient 
for RANK-mediated activation of NF-kB. TRAF2, however, has also been 
strongly linked to the activation of NF-kB by RANK (Rothe et al., 1995). Similar 
domains necessary for the interaction of RANK with TRAF2, TRAF5 and TRAF6 
were identified by Hsu et al. in the C-terminal tail of RANK (Hsu et al., 1999).
One of the key downstream targets of RANK activation is NF-kB. This family of 
transcription factors is regulated by the IkB inhibitory proteins, which in turn are 
regulated by the IKKs (Karin, 1999). The binding of RANKL to its receptor has 
been shown to activate NF-kB in a variety of cells (Anderson et al., 1997; Darnay
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et al., 1998; Wong et al., 1998) and, as previously stated, TRAF2, TRAF5 and 
TRAF6 have been shown to activate NF-kB via interaction with NIK, IKKa and 
IKKp (Malinin et al., 1997; Regnier et al., 1997; Song et al., 1997; Woronicz et 
al., 1997). More recently, NF-kB has been shown to positively or negatively 
regulate the growth of nodose neurons depending on the phosphorylation status 
of the p65 NF-kB subunit (Gutierrez et al., 2005; Gutierrez et al., 2008).
This Chapter reports studies of the involvement of particular TRAF proteins and 
components of the NF-kB signalling network in mediating the neurite growth 
inhibitory effects of RANK in neonatal nodose neurons. These studies involved 
documenting the consequences of co-transfecting the neurons with wild-type or 
mutant RANK expression plasmids together with plasmids expressing dominant- 
negative (DN) TRAF2, TRAF6, NIK, IKKa, IKKp, or NF-kB and figure 32 displays 
the aims of this Chapter. I found that interfering with the function of TRAF2, NIK, 
IKKp or NF-kB, but not TRAF 6 and IKKa, reduces the ability of RANK over­
expressing to inhibit neurite outgrowth from P0 nodose neurons.
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Figure 32: Aims of Chapter 4. RANK can signal via a large number of 
downstream mediators. Experiments were designed to investigate potential 
downstream mediators in PO nodose neurons including members of the NF-B 
signalling pathway.
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Results
4.2 RANK signals via a distinct C-terminal domain to reduce neurite 
outgrowth from neonatal nodose neurons
Investigation into the intracellular signalling pathways that mediate the growth 
inhibitory effects of RANK in developing sensory neurons, began with the 
co-transfection of PO nodose neurons with a YFP expression plasmid, together 
with either an empty control vector, a functional RANK expression construct 
(wt-RANK), or an expression construct encoding a deletion mutant of RANK. The 
regions of RANK deleted in this latter construct were amino acid residues 312 to 
391 and the C-terminal region from residue 544 to 626 (RANK-(A312-391/544- 
626)). These two domains are known to be vital for the interaction of RANK with 
members of the TRAF family (Darnay et al., 1999). Co-transfected neurons were 
incubated for 48 hrs in medium containing BDNF (10ng/ml). Images of 
transfected neurons were captured after 24 hrs in culture to perform Sholl 
analysis to determine the extent of neurite outgrowth under each experimental 
condition. Fluorescent neurons were counted after 24 hrs and 48 hrs in culture to 
allow percentage neuronal survival at 48 hrs to be calculated, compared to the 
number of neurons present at 24 hrs. Over-expression of either wt-RANK or the 
RANK deletion mutant did not alter the survival of nodose neurons compared to 
control transfected neurons (Fig. 33A). In accordance with data in the previous 
Chapter (Fig. 21), over-expressing RANK dramatically reduced the extent of 
neurite outgrowth from PO nodose neurons compared to control transfected
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neurons, as evidenced by a downward shift in the Sholl profile (Fig. 31B), a 
reduction in mean total neurite length (Fig. 33C) and a reduction in the number of 
branch points (Fig. 33D). In contrast, exogenous expression of RANK-(A312-91/ 
544-626) did not result in either a shift in the Sholl profile, a reduction in mean 
total neurite length or a decrease in the mean number of branch points 
compared to controls (Figs. 33B, 33C and 33D, respectively). These data 
suggest that one or both of the domains deleted in RANK-(A312-391/544-626) 
are essential for transducing RANK activation into reduced neurite outgrowth in 
nodose neurons in the presence of BDNF.
Having established that deleting amino acid residues 312-391 and 544-626 
removes the ability of exogenously expressed RANK to inhibit BDNF-promoted 
neurite outgrowth from PO nodose neurons, experiments were designed to 
determine which of these two deleted regions is more important for mediating the 
neurite outgrowth inhibitory effects of RANK. PO nodose neurons were co­
transfected with a YFP expression construct together with an empty control 
plasmid, a wt-RANK expression plasmid, an expression construct encoding a 
RANK receptor lacking amino acid residues 312-391 (RANK-(A312-391)), or a 
RANK expression construct lacking amino acid residues 544-626 (RANK-(544- 
626)). Exogenous expression of wt-RANK or either of the deleted RANK 
isoforms, did not alter the number of neurons surviving after 48 hrs in culture 
compared to control transfected neurons (Fig. 34A). Over-expression of RANK- 
(A312-391) was as effective as over-expression of wt-RANK in reducing the
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extent of neurite outgrowth from PO nodose, as shown by a downwardly shifted 
Sholl profile (Fig. 34B), a reduced mean total neurite length (Fig. 34C) and a 
reduced mean number of branch points (Fig. 34D). In contrast, over-expression 
of RANK-(A544-626) did not significantly alter the Sholl profile of PO nodose 
neurons compared to control transfected cultures (Fig. 34B) nor did it 
significantly reduce the mean total neurite length (Fig. 34C) or the mean number 
of branch points (Fig. 34D) compared to control cultures. These data suggest 
that RANK amino acid residues 544-626, but not residues 312-391, are 
necessary for RANK-mediated inhibition of BDNF-promoted neurite outgrowth 
from neonatal mouse nodose neurons.
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Figure 33. A RANK receptor deficient in two important signalling domains does not effect 
BDNF-dependent neurite growth. P0 nodose neurons were co-transfected 3 hours after plating 
with a YFP expression construct together with either a RANK expression construct, a RANK 
construct deficient in two signalling domains (RANK-(a31 2-391, 544-626)) or an empty vector 
and cultured in medium containing 10ng/ml BDNF for 48hrs. Percentage survival after at 48hrs 
compared to 24 hrs (A). Sholl analysis (B), mean total neurite length (C) and mean number of 
branching points (D) after 24hrs in culture. The results are derived from the grouped data of 50- 
70 neurons and very similar data were obtained in three independent experiments. Statistical 
comparisons are with respect to control-transfected neurons (***p<0.001, ANOVA with Fisher’s 
post hoc).
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Figure 34. The C-terminal tail of RANK mediates its ability to inhibit neurite outgrowth 
from neonatal nodose neurons. P0 nodose neurons were co-transfected 3 hours after plating 
with a YFP expression construct together with either a RANK expression construct, a RANK 
construct deficient in the signalling domain between residues 312 and 391 (RANK-(A312-391)) 
or with a truncated C-terminal tail (RANK-(A544-626)), or an empty vector and cultured in 
medium containing 10ng/ml BDNF for 48 hrs. Percentage survival of neurons at 48hrs compared 
to that after 24 hrs (A). Sholl analysis (B), mean total neurite length (C) and mean number of 
branching points (D) after 24hrs in culture. The results are derived from the grouped data of 50- 
70 neurons and very similar data were obtained in three independent experiments. Statistical 
comparisons are with respect to control-transfected neurons (***p<0.001, ANOVA with Fisher’s 
post hoc).
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4.3 RANK signals via a specific TRAF family member in nodose neurons
Like other members of the TNF superfamily, RANK binds members of the TRAF 
family of intracellular mediators to initiate downstream signalling (Bharti & 
Aggarwal, 2004). Of this family, TRAF2 and TRAF6 are known to be crucial for 
the downstream activation of NF-kB and JNK (Darnay et al., 1999). In order to 
investigate whether TRAF2 or TRAF6 plays a role in transducing elevated RANK 
signalling into reduced BDNF-promoted neurite outgrowth from neonatal nodose 
neurons, PO nodose neurons were plated and co-transfected with a YFP 
expression vector, together with either the wt-RANK expression plasmid alone, 
or the wt-RANK expression construct in combination with either a dominant 
negative TRAF2 (DN-TRAF2) or TRAF6 (DN-TRAF6) expression plasmid. 
Control cultures were co-transfected with the YFP expression plasmid together 
with an empty expression vector. Co-transfected neurons were incubated in 
medium containing BDNF (10ng/ml), and the resultant fluorescent cells were 
counted at 24 and 48 hrs post transfection to allow percentage survival at 48 hrs 
to be calculated. Co-transfection of YFP together with wt-RANK and DN-TRAF6 
did not alter the percentage of nodose neurons surviving compared to control 
transfected cultures (Fig. 35A). Interestingly, co-transfection with this 
combination of plasmids did not alter either the Sholl profile (Fig. 35B), mean 
total neurite length (Fig. 35C) or mean number of branch points (Fig. 35D), 
compared to neurons co-transfected with YFP and wt-RANK in the absence of 
DN-TRAF6. This suggests that TRAF6 is not vital for the transduction of RANK
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activation into inhibition of BDNF-promoted neurite outgrowth from neonatal 
nodose neurons.
Co-transfection of PO nodose neurons with the YFP expression construct 
together with the wt-RANK and DN-TRAF2 expression plasmids reduced the 
survival of PO nodose neurons cultured in the presence of BDNF by 
approximately 50% compared to control transfected cultures (Fig. 35A), a value 
that was highly statistically significant (p<0.001, ANOVA with Fisher’s post hoc). 
Although over-expression of DN-TRAF2 significantly reduced the survival of PO 
nodose neurons compared to neurons co-transfected with YFP and wt-RANK 
expression plasmids, it also partially prevented the ability of exogenously 
expressed wt-RANK to shift the Sholl profile of these neurons downwards (Fig. 
35B), suggesting that TRAF2 may mediate the neurite growth inhibitory effects of 
RANK over-expression in nodose neurons.
To exclude the possibility that the effects of DN-TRAF2 on BDNF-promoted 
survival might confound interpretation of its apparent effects on neurite growth, I 
repeated the co-transfection experiments with YFP, wt-RANK, DN-TRAF2 and 
DN-TRAF6 expression plasmids in the presence of 25pM of the irreversible pan- 
caspase inhibitor Boc-D-FMK to prevent neuronal death. In the presence of this 
caspase inhibitor, over-expression of RANK, either alone or in combination with 
either DN-TRAF2 or DN-TRAF6, did not alter the survival of nodose neurons 
compared to control transfected cultures (Fig. 36A). However, in agreement with
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the data shown in Figures 33B, 33C and 33D, DN-TRAF2 greatly reduced the 
downward shift in the Sholl profile, reduction in total neurite length and number of 
branch points caused by RANK over-expression of RANK in these caspase 
inhibitor containing cultures, whereas DN-TRAF6 had no effect. These findings 
provide additional support for a role of the C-terminal domain of RANK in RANK- 
mediated inhibition of neurite outgrowth (Fig. 34), since TRAF2 interacts with this 
region of the RANK receptor (Darnay et al., 1999). Additional experiments are 
needed to clarify the role of TRAF2 in the regulation of neurotrophin-mediated 
neuronal survival, for example transfection of nodose neurons with the TRAF2 
dominant negative expression plasmid only. However, the requirement for 
caspase inhibition to prevent the decrease in survival seen when interfering with 
TRAF2 activity raises the possibility that TRAF2 regulates caspase activity. 
Further experiments to clarify the possible role of TRAF2 in the regulation of the 
caspase activity are necessary.
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Figure 35. Blocking the function of TRAF2 reduces the survival of nodose neurons 
cultured with BDNF. P0 nodose neurons were co-transfected 3 hours after plating with a YFP 
expression construct together with either a RANK expression plasmid alone or a RANK 
expression plasmid in combination with either a dominant-negative TRAF2 (DN-TRAF2)or a DN- 
TRAF6 expression plasmid. Control cultures were co-transfected with the YFP plasmid together 
with an empty expression vector. Neurons were cultured in medium containing 10ng/ml BDNF 
for 48 hrs. Percentage neuronal survival at 48hrs compared to that at 24 hrs (A). Sholl analysis 
(B), mean total neurite length (C) and mean number of branching points (D) after 24hrs in 
culture. The results are derived from the grouped data of 50-70 neurons and very similar data 
were obtained in three independent experiments. Statistical comparison are with respect to 
control-transfected neurons (**p<0.01, ***p<0.001, ANOVA with Fisher’s post hoc).
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Figure 36. TRAF2 mediates RANK’S ability to inhibit BDNF-promoted neurite outgrowth 
from P0 nodose neurons. P0 nodose neurons were co-transfected 3 hours after plating with a 
YFP expression construct together with either a RANK expression plasmid alone or a RANK 
expression plasmid in combination with either a dominant-negative TRAF2 (DN-TRAF2) 
expression construct or a DN-TRAF6 expression plasmid. Control cultures were co-transfected 
with the YFP plasmid and an empty vector. Co-transfected neurons were cultured for 48 hrs in 
medium containing 10ng/ml BDNF and 25pM of the pan-caspase inhibitor, Boc-D-FMK. 
Percentage neuronal survival after 48hrs in culture compared to that after 24hrs (A). Sholl 
analysis (B), mean total neurite length (C) and mean number of branching points (D) after 24hrs 
in culture. The results are derived from the grouped data of 50-70 neurons and very similar data 
were obtained in three independent experiments, ‘ “ denotes p<0.001 when data are compared 
with control transfected neurons (ANOVA with Fisher’s post hoc). * denotes p<0.05 when data 
are compared to neurons transfected with YFP and RANK alone (ANOVA with Fisher’s post 
hoc).
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4.4 RANK signals via NIK to inhibit neurite outgrowth from nodose neurons
NIK has previously been shown to link RANK activation to increased NF-kB 
activity in HEK293 cells (Darnay et al., 1999), raising the possibility that NIK may 
be a downstream target of activated RANK in neonatal nodose neurons. To 
investigate this possibility, I co-transfected PO nodose neurons 3 hours after 
plating with a YFP expression plasmid together with either a RANK expression 
construct alone, an expression vector encoding a function blocking dominant- 
negative NIK (DN-NIK) alone or the RANK expression plasmid in combination 
with the DN-NIK expression construct. These neurons were cultured in medium 
containing 10ng/ml BDNF, and fluorescent neurons were counted after 24 and 
48 hrs in culture to allow calculation of percentage survival at 48 hrs. Images of 
fluorescent neurons were captured after 24 hrs for Sholl analysis to determine 
the extent of neurite outgrowth under each experimental condition. Exogenous 
expression of either RANK or DN-NIK alone, or a combination of RANK plus DN- 
NIK, did not significantly affect the survival of nodose neurons compared to 
control transfected neurons (Fig. 37A). In accordance with previous data (Fig. 
21), over-expression of RANK dramatically reduced the extent of neurite 
outgrowth from PO nodose neurons compared to control transfected neurons 
(Figs. 37B, 37C and 37D). Although exogenous expression of DN-NIK alone did 
not affect the extent of neurite outgrowth compared to control transfected 
neurons, co-expression of DN-NIK with RANK completely blocked the ability of 
over-expressed RANK to reduce neurite outgrowth as shown by the Sholl profile 
(Fig. 37B), mean total neurite length (Fig. 37C) and mean number of branch
131
points (Fig. 37D) of processes projecting from neonatal nodose neurons cultured 
in the presence of BDNF. Taken together, this data suggests that NIK does not 
mediate BDNF-promoted neurite outgrowth from neonatal nodose neurons, but it 
is a crucial signalling intermediate in the pathway that leads from RANK over­
expression to inhibition of neurite outgrowth. This experiment also raises 
questions regarding the role of RANK in the negative regulation of neurite growth 
from nodose neurons. Constitutive activation of RANK would require the active 
involvement of NIK in the negative regulation of neurite growth, suggesting that 
interference with NIK signalling, via overexpression of the NIK dominant negative 
expression construct, would prevent downstream signalling of RANK. However, 
overexpression of the NIK dominant negative construct has no effect on the 
growth of nodose neurons supported by BDNF. This raises the possibility that 
RANK may not be constitutively active, a finding that would concur with 
experiments overexpressing RANK constructs deficient in vital signalling 
domains which fail to increase the growth of BDNF supported nodose neurons 
relative to control transfected neurons (Figs 33 and 34). Further confusing the 
issue is the fact that overexpression of plasmids designed to interfere with NF-kB 
signalling show that NF-kB is constitutively active and that NF-kB can either 
promote or inhibit neurite growth from nodose neurons (Gutierrez et al., 2005; 
Gutierrez et al., 2008). Further experiments designed to block constitutive RANK 
activity, such as RANK blocking antibodies, are required to clarify the role of 
RANK in the regulation of neurotrophin-mediated neurite growth.
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Figure 37. NIK plays a role in transducing RANK activation into reduced neurite outgrowth 
from neonatal nodose neurons. P0 nodose neurons were co-transfected, 3 hours after plating, 
with a YFP expression construct together with either a RANK expression construct or a dominant- 
negative NIK (DN-NIK) expression plasmid alone, or a combination of RANK and DN-NIK 
expression plasmids. Control cultures were co-transfected with the YFP expression plasmid and an 
empty expression vector. Co-transfected neurons were cultured for 48rs in medium containing 
10ng/ml BDNF. Percentage neuronal survival after 48hrs compared to 24hrs (A). Sholl analysis (B), 
mean total neurite length (C) and mean number of branching points (D) after 24hrs of culture. The 
results are derived from the grouped data of 50-70 neurons and very similar data were obtained in 
three independent experiments. Statistical comparisons are with respect to control-transfected 
neurons (***p<0.001, ANOVA with Fisher’s post hoc).
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4.5 IKKp plays a role in mediating RANK induced inhibition of neurite 
growth
NF-kB is normally sequestered in an inactive state within the cell cytoplasm by 
IkBo . The IkB kinases, IKKa and IKKp, regulate the function of NF-kB by 
phosphorylating kBa, which results in the release of NF-kB from its inhibitory 
complex with kBa and its subsequent translocation to the nucleus (Mercurio & 
Manning, 1999). To investigate whether IKKa or IKKp link NIK activation to NF- 
kB activation and subsequent inhibition of neurite outgrowth from PO nodose 
neurons, cells were co-transfected 3 hrs after plating with an expression plasmid 
encoding YFP together with either a RANK expression construct alone or a 
RANK expression construct in combination with either a dominant-negative IKKa 
(DN-IKKa) or IKKp (DN-IKKp) expression plasmid (Fig 38; Dr H Gutierrez, 
personal communication). Control neurons were co-transfected with the YFP 
expression plasmid together with an empty expression vector. Co-transfected 
neurons were incubated for 48 hrs in medium containing 10ng/ml BDNF. 
Fluorescent neurons were counted after 24 hrs and 48 hrs in culture to allow 
percentage survival at 48 hrs to be calculated. In addition, transfected neurons 
were imaged for Sholl analysis of the extent of neurite outgrowth after 24 hrs in 
culture. None of the combinations of co-transfected plasmids altered the survival 
of neonatal nodose neurons compared to control transfected neurons (Fig. 38A). 
Co-transfection of DN-IKKa with RANK and YFP expression plasmids did not 
ameliorate the ability of RANK to greatly reduce the extent of neurite outgrowth 
from PO nodose neurons (Figs. 38B, 38C and 38D). In contrast, exogenous
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expression of DN-IKKp almost completely abolished the ability of over-expressed 
RANK to inhibit neurite outgrowth from these neurons (Figs. 38B, 38C and 38D), 
suggesting that IKKp plays a vital role in transducing RANK over-expression into 
reduced neurite growth.
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Figure 38. RANK signals via IKKp in to reduce neurite outgrowth from neonatal nodose 
neurons. P0 nodose neurons were co-transfected with a YFP-expression plasmid together with 
either a RANK expression plasmid alone or a RANK expression plasmid in combination with 
either a dominant-negative IKKa (DN-IKKa) or DN-IKKp expression. Control cultures were co­
transfected with the YFP expression plasmid plus an empty expression vector. Co-transfected 
neurons were cultured for 48hrs in medium containing 10ng/ml BDNF. (A) percentage survival 
of co-transfected neurons at 48hrs compared to 24hrs. (B) Sholl analysis of neurite arbour 
morphology (C) mean total neurite length (D) mean number of branch points after 24hrs of 
culture. The means and standard errors obtained from 60-70 neurons in each experimental 
condition are shown. Statistical comparisons are with respect to control-transfected neurons 
(*p<0.05, **p<0.01, ANOVA with Fisher’s post hoc).
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4.6 RANK signals via NF-kB in nodose neurons cultured with BDNF
As discussed in Chapter 4.5, NF-kB is held in an inactive form in the cytoplasm 
by kBa, and IKKs release NF-kB via phosphorylation and subsequent ubiquitin- 
mediated degradation of the inhibitory protein complex. Preventing NF-kB from 
translocating to the nucleus by expression of a super-repressor form of kBa 
(SR-kBa) that cannot be phosphorylated to release sequestered NF-kB, is an 
effective way of disabling NF-kB canonical signalling. This approach was used to 
investigate whether NF-kB activity is required to mediate the neurite outgrowth 
inhibitory effects of RANK over-expression in PO nodose neurons (Fig 39; Dr H 
Gutierrez, personal communication). Neurons were ballistically co-transfected, 
shortly after plating with a YFP expression vector together with either a RANK 
expression plasmid alone, a SR-kBa expression construct alone or a 
combination of RANK and SR-kBa expression plasmids together. Co­
transfected neurons were cultured for 48 hrs in medium containing 10ng/ml 
BDNF. Fluorescent neurons were counted after 24 hrs and 48 hrs in culture, for 
the assessment of neuronal survival, and imaged after 24 hrs for Sholl analysis. 
Co-transfection of each of the expression plasmid combinations did not reduce 
neuronal survival compared to control transfected cultures (Fig. 39A). Once 
again, over-expression of RANK significantly reduced the extent of neurite 
outgrowth from PO nodose neurons compared to control transfected neurons, as 
seen by a downward shift in the Sholl profile (Fig. 39B), a reduction in the mean 
total neurite length (Fig. 39C) and a reduction in the mean number of branch
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points (Fig. 39D). Significantly, co-expression of SR-kBa together with RANK 
completely abolished the ability of RANK to reduce neurite outgrowth from 
neonatal nodose neurons, suggesting that RANK over-expression inhibits neurite 
extension and branching by an NF-kB dependent mechanism (Figs. 39B, 39C 
and 39D). Interestingly, exogenous expression of SR-kBa alone resulted in a 
downward shift in the Sholl profile, compared to control transfected neurons (Fig. 
39B), as well as a reduction in mean total neurite length (Fig. 39C) and mean 
number of branch points (Fig. 39D). This observation is in accordance with 
previously published data demonstrating that NF-kB mediates BDNF-promoted 
neurite outgrowth from developing nodose neurons (Gutierrez et al., 2005; 
Gutierrez et al., 2008). My data suggest that NF-kB activation is important for 
both BDNF-promoted neurite outgrowth from nodose neurons and RANK over­
expression induced inhibition of neurite outgrowth from the same neurons. These 
somewhat conflicting data are intriguing and warrant further investigation. 
Previous results have shown that NF-kB can either positively regulate the growth 
of nodose neurons (Gutierrez et al., 2005) or may indeed negatively regulate 
neurite growth from these neurons (Gutierrez et al., 2008) and RANK may play a 
role in regulating the function of NF-kB and the subsequent effect on the growth 
of nodose neurons at this stage of development.
Figure 40 shows a schematic representation of the proposed pathway that leads 
to the activation of NF-kB and subsequent inhibition of neurite outgrowth 
following RANK over-expression in P0 nodose neurons. RANK acts through its
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C-terminal tail to activate TRAF2, which in turn activates NIK, IKKp and finally 
NF-kB to regulate neurite outgrowth from PO nodose neurons.
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Figure 39. RANK signals via NF-kB in neonatal nodose neurons. P0 nodose neurons 
were co-transfected with a YFP-expression plasmid together with either a RANK expression 
plasmid alone, a super-repressor IkBa (SR-lkBa) expression construct alone or RANK and 
SR-lkBa expression plasmids together. Control cultures were co-transfected with the YFP 
expression plasmid and an empty expression vector. Co-transfected neurons were cultured 
for 48hrs in medium containing 10ng/ml BDNF. Fluorescent neurons were counted after 
24hrs and 48hrs in culture and imaged for Sholl analysis after 24hrs in culture. (A) Pecentage 
neuronal survival at 48hrs compared to 24hrs. (B) Sholl analysis of neurite arbour 
morphology, (C) mean total neurite length and (D) mean number of branch points 24 hrs after 
transfection. The means and standard errors obtained from 60-70 neurons in each 
experimental condition are shown. Statistical comparisons are with respect to control- 
transfected neurons (*p<0.05, **p<0.01, ANOVA with Fisher’s post hoc).
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Fig 40. Proposed pathway of RANK signal transduction in nodose neurons. RANK signals 
via a defined section of the C-terminal tail and then via TRAF2, NIK, IKK and NF- kB in the 
regulation of the growth of PO nodose neurons. (Adapted from Bharti & Aggarwal, 2004.)
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4.7 Discussion
In Chapter 3, I provided evidence for a novel role for RANK in the regulation of 
neurite outgrowth from developing neurons of the nodose, SCG and trigeminal 
ganglia. In this Chapter, I have used ballistic co-transfection of expression 
constructs to define the pathway that appears to transduce RANK over­
expression, and presumed activation, into the inhibition of neurite outgrowth from 
developing nodose neurons at a time in their development when they are 
establishing and refining connections with their peripheral and central targets. 
Initially, by studying the consequences of expressing RANK deletion mutants, I 
demonstrated that the growth inhibitory effects of over-expressing RANK in 
nodose neurons requires the C-terminal end of the protein, from amino acid 
residues 544 to 626. This section of the receptor is vital for interaction with two 
members of the TRAF family, TRAF2 and TRAF5 (Darnay et al., 1999; Wong et 
al., 1998; Hsu et al., 1999) both of which are known to activate NF-kB and JNK. 
Accordingly, co-transfection of nodose neurons with a RANK expression 
construct in combination with dominant-negative TRAF expression plasmids, 
clearly demonstrated that functional TRAF2, but not TRAF6, was an essential 
part of the signalling pathway that leads from RANK over-expression to inhibition 
of BDNF-promoted neurite growth. Because exogenous DN-TRAF2 expression 
significantly reduced the survival of PO nodose neurons cultured in medium 
containing BDNF, these experiments were performed in the presence of caspase 
inhibitors. The apoptosis-inducing effect of DN-TRAF2 was somewhat surprising, 
since TRAF2 has not previously been shown to interact with either TrkB or p75
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neurotrophin receptors. Interestingly, although TRAF6 interacts with p75 and can 
either promote neuronal survival by mediating downstream activation of NF-kB or 
promote apoptosis by mediating downstream activation of JNK (Reichardt, 
2006), over-expression of DN-TRAF6 did not affect the survival of PO nodose 
neurons. Further investigation of the roles of other TRAF family members, 
especially TRAF5, which interacts with the cytoplasmic C-terminal tail of RANK, 
are warranted to explore the role of these intracellular mediators in regulating 
RANK signalling in nodose neurons.
Having demonstrated that TRAF2 mediates the ability of RANK to inhibit neurite 
outgrowth from neonatal nodose neurons, I went on to examine whether NIK, a 
downstream target of TRAF2 and an activator of IKKs and hence NF-kB (Malinin 
et al., 1997; Regnier et al., 1997; Song et al., 1997; Woronicz et al., 1997), was 
also involved in transducing the neurite growth inhibitory effects of RANK over­
expression. Exogenous expression of a DN-NIK plasmid had no effect on the 
growth and survival of PO nodose neurons cultured in medium containing BDNF, 
suggesting that this kinase does not play a role in the regulation of BDNF- 
mediated growth and survival induced by activation of TrkB and p75. 
Co-expression of RANK and the DN-NIK expression plasmid, however, 
prevented the decrease in neurite growth seen when expressing the RANK 
construct alone, suggesting that this kinase is vital for the regulation of RANK 
signalling in PO nodose neurons. TRAF2 is a key regulator of NIK activity 
(Malinin et al., 1997) and the stimulation of NF-kB by TRAF2 requires NIK
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activity (Ramakrishan et al., 2004). These results provide evidence for the 
involvement of NIK in mediating the neurite growth inhibitory effects of RANK 
over-expressing.
The next intracellular mediators to be investigated were members of the IKK 
family, transducers vital for the activation of canonical NF-kB signalling (Mercurio 
& Manning, 1999). Blocking IKK signalling by over-expressing dominant negative 
constructs targeted at IKKa or IKKp did not affect the survival of nodose neurons 
co-transfected with a RANK expression plasmid and cultured with BDNF. Co­
transfection of RANK with a dominant negative IKKp, but not a dominant 
negative IKKa, was found to prevent the decrease in neurite growth seen when 
over-expressing RANK, suggesting IKKp is crucial for RANK signalling in PO 
nodose neurons. IKKp is vital for canonical NF-kB signalling, and has been 
shown to be activated by NIK (Regnier et al., 1997). The requirement for IKKp in 
the negative regulation of neuritic outgrowth by RANK further expands the role 
this kinase plays in the regulation of RANK signalling.
Finally, I investigated the participation of kBa, a central regulatory component of 
the canonical NF-kB signalling pathway, in the neurite growth inhibitory effects of 
RANK over-expressing. Transfecting nodose neurons with a super-repressor 
form of kBa that prevents NF-kB canonical signalling prevented the neurite 
growth inhibitory effects of co-expressed RANK without affecting neuronal 
survival, demonstrating that canonical NF-kB signalling is essential for the
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neurite growth inhibitory effects of RANK over-expressing in nodose neurons 
cultured with BDNF. At first glance this result seems surprising as NF-kB has 
previously been shown to play a role in positively regulating neurite growth from 
nodose neurons at this stage in development (Gutierrez et al., 2005). However, 
NF-kB has subsequently been shown to negatively regulate neurite growth from 
nodose neurons, depending on the phosphorylation status of p65 on serine 536 
(Gutierrez et al., 2008). Thus NF-kB activation can either promote (when serine 
536 is dephosphorylated) or negatively regulate neurite growth (when serine 536 
is phosphorylated) (Gutierrez et al., 2005; Gutierrez et al., 2008). In addition to 
activating NF-kB, IKKp over-expression in nodose neurons leads to 
phosphorylation of p65 on serine 536, conferring a growth inhibitory function on 
NF-kB (Gutierrez et al., 2008). These findings are entirely consistent with my 
demonstration that the neurite growth inhibitory effects of RANK depend on both 
IKKp and NF-kB activation. However, in future work it will be important to 
confirm the anticipated phosphorylation of p65 on serine 536 following RANK 
over-expressing in nodose neurons.
I have dissected the components of a pathway that appears to play a role in the 
regulation of neurite growth from nodose ganglion sensory neurons supported by 
BDNF at a time in development when the axons of these neurons are ramifying 
in their targets and refining their connections. The neurite growth inhibitory effect 
of RANK over-expression requires the involvement of the intracellular mediators 
TRAF2, NIK, IKKp and NF-kB. This pathway is a novel mechanism for the
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regulation of BDNF-mediated neurite growth in nodose neurons. However, this 
pathway significantly varies from other known RANK signalling pathways. 
Darnay et al. found that the TRAF6 binding site, between positions 340 and 358, 
is necessary and sufficient for the activation of NF-kB in embryonic kidney 293 
cells and that the binding sites for TRAF2 and 5, located further along the C- 
terminal tail, were required for RANK-induced JNK activation (Darnay et al., 
1998). In contrast, my results suggest that the C-terminal tail, the domain that 
interacts with TRAF2 and TRAF5, is essential for the reduction in neurite growth 
seen when over-expressing RANK, and that TRAF2 and NF-kB are required for 
the negative regulation of neurite growth mediated by RANK in nodose neurons.
Further investigation of RANK signalling pathways, along with the role RANK 
plays in the development of other neuronal populations, is essential in order to 
understand the function this receptor plays in neuronal development. The use of 
knockout mice, such as TRAF2 (Yeh et al., 1997), TRAF6 (Lomaga et al., 2000) 
and TRAF5 deficient mice (Nakano et al., 1999), would also further our 
understanding of the role the TRAFs play in the regulation of BDNF-mediated 
neuronal survival and the negative regulation of neurite growth mediated by 
RANK in sensory neurons. Likewise, studying the consequences of targeted 
deletion of the RANK gene in developing neurons will be crucial in defining the 
precise roles of RANK signalling in these cells. Additional experiments could also 
focus on the possible requirement of other important intracellular mediators in 
RANK-regulated neurite outgrowth from sensory neurons. Other potential targets
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involved in the regulation of RANK signalling include Akt (Wong et al., 1999), 
members of the MAPK family such as p38 (Matsumoto et al., 2000) and ERK 
(Karin, 1996).
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Chapter 5
Roles of MEK/ERK and PI3K/Akt signalling in neurite growth from 
developing nodose neurons
148
5.1 Introduction
Several intracellular signalling cascades mediate the effects of activation of the 
RANK receptor complex (Bharti & Aggarwal, 2004). These include members of 
the TRAF family, JNK, PI3K, NF-kB and members of the MAPK family. Because 
ERK and PI3K have been implicated in regulating the growth of neural 
processes, I began investigating the role these signalling proteins play in 
mediating the effects of RANK over-expressing in nodose ganglion neurons. 
However, in the course of optimizing the experimental conditions for these 
studies, I made several completely unexpected and very surprising findings 
relating to the functions of these signalling proteins in nodose neurons, which are 
the topic of this chapter in addition to their roles in RANK signalling.
One of the most extensively studied and best understood MAPK signalling 
pathways is the ERK1/2 cascade (Krishna & Narang, 2008). This cascade is 
activated by a variety of extracellular and intracellular stimuli including G protein- 
coupled receptors and receptor tyrosine kinases. Small G proteins, such as Ras, 
then transduce the signal to Raf kinases which phosphorylate ERK kinases 
(MEK) -1 and -2. These in turn phosphoylate ERK1/2, which then activates over 
150 substrates including cytosolic and membrane proteins, substrates in the 
nucleus and cytoskeletal proteins. The principal role of ERK is as a crucial 
regulator of survival, cell growth and proliferation in many cell types (Junttila, et 
al., 2008). In neuronal populations, the primary role of ERK is in the regulation of
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differentiation and cell fate determination (Samuels et al., 2009) but ERK also 
regulates the genesis of neural progenitors, learning and memory processes and 
neurite growth in some neuronal populations including embryonic neurons of the 
chick retina, hippocampal neurons and sensory neurons (Perron & Bixby, 1999; 
Veeranna et al., 1998; Liu & Snider, 2001). ERK has also been shown to be 
involved in the positive regulation of NGF-mediated neurite growth in mouse 
SCG neurons (O’Keeffe et al., 2008).
Akt, also known as PKB, is one of the most important intracellular regulators in 
eukaryotic cells. In most cell types its primary function is the regulation of cell 
survival and because of this it has been implicated in cancer in many instances. 
Akt also has roles in a variety of other processes including cell-cycle progression 
and transcriptional regulation (Brazil et al., 2004; Duronio V, 2008). The key 
upstream regulator of Akt is PI3K, a membrane bound enzyme which generates 
phospholipids crucial for the activation of Akt (Brazil & Hemmings, 2001). PI3K is 
itself activated by receptor tyrosine kinases in response to cytokines, growth 
factors and neurotrophins (Rodgers & Theibert, 2002). Akt plays a critical role in 
the regulation of survival in a variety of neuronal populations (Brunet et al., 2001) 
including cerebellar (Dudek et al. 1997) and sympathetic neurons (Philpott et al., 
1997; Crowder & Freeman, 1998). Akt is also known to regulate neuritic growth 
in neuronal populations including sensory neurons (Gallo, & Letourneau, 1998; 
Liu & Snider, 2001).
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The growth and survival of nodose neurons is supported by a variety of different 
factors. BDNF, a member of the neurotrophin family, promotes the survival and 
neurite growth of nodose neurons in vitro (Davies et al., 1993). BDNF signals 
through TrkB and is known to activate many downstream pathways including 
Ras, MAPK, PI3K and PLC-y (Patapoutian & Reichardt, 2001; Huang & 
Reichardt, 2003; Chao, 2003).
In order to investigate whether PI3K and ERK signalling cascades are involved in 
mediating the effects of RANK signalling in sensory neurons, the role of these 
mediators in BDNF-mediated survival and neurite growth in nodose neurons was 
first explored. Selective inhibitors were used to block activation of these kinases 
in nodose neurons supplemented with BDNF. My findings suggest that while 
PI3K signalling contributes to BDNF-promoted neurite growth, ERK acts, 
paradoxically, to limit BDNF-promoted neurite growth. Western blot analysis 
revealed that whereas BDNF increased Akt phosphorylation, it did not affect the 
levels of phosphorylated ERK.
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Results
5.2 U0126 and PD98059 increase BDNF-promoted neurite growth from 
nodose neurons
The involvement of the MEK/ERK signalling cascade in mediating BDNF 
promoted survival and neurite outgrowth from neonatal mouse nodose neurons 
was investigated though the use of inhibitors directed against this pathway. 
Dissociated PO nodose neurons were incubated in defined medium containing 
U0126 (10pM), a MEK1/2 inhibitor, for 2 hours prior to the addition of BDNF to 
the medium. The neurons were counted after the addition of BDNF and after a 
further 24 hours time period to calculate percentage survival. These counts 
showed that inhibiting MEK had no effect on BDNF promoted survival (Fig. 41 A). 
Cells were imaged using the vital dye Calcein-AM, after 24 hours for Sholl 
analysis of neurite size and complexity. U0126 was found to have a significant 
effect on neurite growth from neurons cultured in the presence of BDNF, 
increasing the size of neuritic arbors with respect to controls (Fig. 41B). Total 
number of branch points (Fig. 41D) and total neurite length (Fig. 41C) were 
increased by around 50% following MEK inhibition. Figure 44 shows the typical 
appearance of neurons incubated with BDNF with and without U0126.
To order to confirm the role of MEK in the regulation of neurite growth from 
nodose neurons cultured with BDNF, the neurons were treated with another 
MEK inhibitor. PO nodose neurons were incubated in medium containing
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PD98059 (25pm) for 2 hours before the addition of BDNF (10ng/ml) to the 
medium. The number of neurons was counted after the addition of BDNF and 
again at 24 hours to allow percentage neuronal survival after 24hrs to be 
calculated. Calcein-AM stained neurons were also imaged at 24 hours for Sholl 
analysis of neurite growth. PD98059 was found to increase the growth of these 
neurons by around 50% with respect to controls (Fig. 42). Inhibiting MEK with 
PD98059 had no effect on the survival of PO nodose neurons relative to controls 
(Fig. 42A) but increased the mean total length of neuritic arbors (Fig. 42C) as 
reflected by a shift in the Sholl analysis profile (Fig. 42B). Figure 44 shows the 
typical appearance of neurons incubated in PD98059 for 2 hours prior to the 
addition of BDNF compared to control neurons. Taken together, these data with 
MEK1/2 inhibitors suggest that MEK1/2 signalling normally restricts the extent of 
BDNF promoted neurite outgrowth from neonatal nodose neurons. This is a 
surprising result and will be discussed in more detail in section 5.7.
5.3 BDNF exposure does not alter the levels of phosphorylated ERK1/2 in 
nodose neurons
It is well established that BDNF can activate MAPK signalling cascades 
(Patapoutian & Reichardt, 2001; Huang & Reichardt, 2003; Chao, 2003) and that 
these cascades have functions in several neuronal populations (Samuels et al., 
2009, Perron & Bixby, 1999). The phosphorylation status of ERK1/2 is essential 
to its function. In order to further explore the roles of MEK signalling in mediating 
BDNF promoted survival and neurite outgrowth, levels of phosphorylated 
ERK1/2 were quantified by western blotting following BDNF stimulation. P0
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nodose neurons were plated for two hours in neurotrophin free medium then 
exposed to BDNF for a range of times from 5 minutes to two hours. Neurons 
were then lysed, followed by protein extraction and western blotting. The effect of 
BDNF exposure on the levels of phosphorylated ERK1/2 was examined using 
antibodies directed against the phosphorylated and non-phosphorylated forms of 
the proteins. Levels of phosphorylated ERK1/2 remain constant, as shown in 
Figure 43, despite increasing times of exposure to BDNF. This suggests that 
BDNF exposure does not alter levels of phosphorylated ERK1/2 and that BDNF 
may not regulate the activity of ERK in this neuronal population under this 
particular experimental paradigm.
Taken together, these results suggest that inhibiting MEK in nodose neurons 
markedly increases neurite growth without affecting survival, suggesting that 
MEK plays a role in limiting BDNF mediated neurite growth. The lack of effect of 
BDNF on ERK phosphorylation raises the possibility that MEK exerts its effect on 
neurite growth by an ERK-independent mechanism. As this results is so 
surprising, further experiments using known controls, such as the effect of MEK 
inhibition in cultures from DRG, would confirm the role of MEK in the regulation 
of BDNF-mediated growth from nodose neurons.
5.4 MEK/ERK is not crucial for the effect of over-expressing RANK
As MAPKs are known to be involved in RANK signalling (Bharti & Aggarwal, 
2004), I decided to investigate whether the MEK/ERK signalling cascade was
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crucial for RANK signalling in nodose neurons. In order to overcome the effect of 
blocking MEK on the growth of these neurons, I investigated whether this effect 
was abrogated by the addition of BDNF either concurrently with or prior to the 
addition of the inhibitor. PO nodose neurons were cultured and plated and BDNF 
was then added to the media either at the same time as U0126 or at 1 or 2 hours 
prior to the addition of the blocker. Adding the inhibitor 2 hours prior to the 
addition of the neurotrophic factor gave a significant increase in the growth of 
neuritic arbors (Fig. 41). Concurrent addition of the inhibitor and the neurotrophic 
factor, or incubation of the cells in BDNF for 1 or 2 hours prior to the addition of 
the inhibitor, significantly reduced the effect on neurite growth to the point where 
it was no longer significant (Fig. 45). When the neurons were exposed to BDNF 
first, neurite growth (Fig. 45B), mean total length (Fig. 45C) and mean number of 
branching points (Fig. 45D) were not found to be significantly different than 
controls. This suggests that the timing of the addition of the inhibitor is crucial for 
the MEK-mediated inhibition of BDNF-promoted neurite growth.
In order to investigate whether MEK is crucial for the effect of over-expressing 
RANK on neurite growth, PO nodose neurons were transfected with the RANK 
expression plasmid in the presence of the MEK1/2 inhibitor. The inhibitor was 
added to the culture media concurrently with BDNF, to prevent the increase in 
neurite growth seen when blocking this kinase prior to the addition of the 
neurotrophic factor (Fig. 45). Blocking MEK1/2 did not prevent the reduction in 
neurite growth seen when over-expressing RANK (Fig. 46). Mean total length
155
(Fig. 46C), and mean number of branching points (Fig. 46D) were comparable to 
neurons transfected with the RANK expression construct only. This was also 
reflected in the Sholl profile (Fig. 46B). These results suggest that MEK is not 
crucial for RANK mediated inhibition of neurite outgrowth from nodose neurons. 
Further experiments characterizing the involvement of other intracellular 
mediators in the regulation of RANK signalling are required.
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Figure 41: Effect of U0126 on BDNF-dependent growth from sensory neurons. P0
nodose neurons were treated with either U0126 (10pM) or DMSO (control) for two hours prior 
to the addition of BDNF (10ng/ml). Neurons were fluorescently labelled with Calcein-AM dye 
and images were digitally acquired for analysis of neurite growth and morphology 24 hours 
after plating. Percentage survival after 24 hours (A). Sholl analysis (B), total neurite length (C) 
and number of branching points (D). The results are derived from the grouped data of three 
independent experiments. Statistical comparison are with respect to DMSO treated neurons 
(***p<0.001, ANOVA with Fisher’s post hoc).
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Figure 42: Effect of PD98059 on BDNF-dependent growth from sensory neurons. P0
nodose neurons were treated with either PD98059 (25pM) or DMSO (control) for two hours 
prior to the addition of BDNF (10ng/ml). The neurons were fluorescently labelled with 
Calcein-AM dye and images were digitally acquired for analysis of neurite growth and 
morphology 24 hours after plating. Percentage survival after 24 hours (A). Sholl analysis (B), 
total neurite length (C) and number of branching points (D). The results are derived from the 
grouped data of three independent experiments. Statistical comparison are with respect to 
DMSO treated neurons (***p<0.001, ANOVA with Fisher’s post hoc).
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Figure 43: BDNF does not promote ERK1/2 phosphorylation in sensory neurons.
Western blots showing phospho-ERK1/ERK2 and total ERK1/ERK2 in PO nodose 
neurons treated with 10ng/ml BDNF for times ranging from 5 to 120 min (O’ represents 
cultures not treated with BDNF). These experiments were repeated three times with 
consistent results.
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Figure 44: Effect of MEK inhibitors on BDNF dependent-growth in sensory neurons. (A)
Photomicrographs of typical PO nodose neurons incubated for two hours with MEK inhibitors 
before the addition of BDNF and imaged at 24 hours. Scale bar = 50pm. (B) Proposed 
pathway for the role of ERK/MEK in BDNF mediated neuronal growth.
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Figure 45: Adding BDNF at the same time or before the addition of U0126 
abrogates its effect on neurite growth in sensory neurons. U0126 (10pM) was 
added to P0 nodose neuronal cultures either at the same time as BDNF (10ng/ml) 
(U0126) or after 1 (U0126 1HR) or 2 hours (U0126 2HR). Neurons were fluorescently 
labelled with calcein-AM dye and images digitally acquired for analysis of neurite growth 
and morphology 24 hours after plating. (A) Percentage survival after 24 hours. (B) Sholl 
analysis of neurite growth. Mean total neurite length (C) and mean number of branching 
points (D). Results are derived from the grouped data of three independent experiments. 
Statistical comparison are with respect to DMSO treated controls (*p<0.05, **p<0.01, 
ANOVA with Fisher’s post hoc).
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Figure 46: Blocking ERK1/2 does not prevent the effect of overexpressing RANK 
in sensory neurons. P0 nodose neurons were transfected with a YFP expression 
construct with or without a RANK expression construct and cultured with BDNF 
(10ng/ml) with or without U0126 (10pM). Neurons were fluorescently labelled with 
calcein-AM dye and images digitally acquired for analysis of neurite growth and 
morphology 24 hours after plating. (A) Percentage survival after 24 hours. (B) Sholl 
analysis of neurite growth. Mean total neurite length (C) and mean number of branching 
points (D) in the neurite arbours of 60-70 neurons in each condition from a typical 
experiment are shown (means ± standard errors). Very similar data were obtained in 
three independent experiments. Statistical comparison are with respect to YFP 
transfected controls (***p<0.001, ANOVA with Fisher’s post hoc).
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5.5 Wortmannin and LY294002 decrease the growth of BDNF supplemented 
nodose neurons
To investigate whether PI3K is involved in mediating the survival-promoting and 
neurite growth-promoting effects of BDNF from nodose neurons, dissociated 
cultures of these neurons established from newborn mice were incubated in 
medium containing wortmannin (50nM), a specific PI3K inhibitor, for 2 hours prior 
to the addition of BDNF. The neurons were counted after the addition of the 
neurotrophin and again 24 hours later to calculate percentage neuronal survival. 
Wortmannin was found to have no effect on the BDNF-promoted survival (Fig. 
45A). After 24 hours, the neurons were stained using Calcein-AM and imaged for 
Sholl analysis. Neurons pre-incubated in wortmannin grew significantly less than 
respective controls (Fig. 47). Wortmannin significantly reduced the extent of 
neurite growth (Fig. 47B), mean total length (Fig. 47C) and mean number of 
branching points (Fig. 47D). In the case of mean neurite length, Wortmannin 
reduced the extent of process outgrowth by around 30% and the reduction in the 
number of branch points with wortmannin was 25%.
To confirm the role of PI3K in the regulation of BDNF-mediated neurite growth, 
P0 nodose neurons were cultured in media containing another selective blocker 
of PI3K, LY294002 (50pM), for two hours prior to the addition of BDNF (10ng/ml) 
to the media. The neurons were counted after the addition of the inhibitor and at 
24 hours to calculate survival. These counts showed that LY294002 had no
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effect on the survival of these neurons (Fig. 48A). Inhibition of PI3K with 
LY294002 decreased the mean total neurite length and mean number of branch 
points of PO nodose neurons relative to controls by around a third (Fig. 48C and 
48D). This effect on neurite growth was reflected in a downward shift of the Sholl 
profile of neurons treated with LY294002 compared to controls (Fig. 48B). Figure 
50 shows representative images of PO nodose neurons treated with wortmannin 
and LY294002. Together, these results suggest a role for PI3K in positively 
regulating the BDNF-mediated neuritic growth from PO nodose neurons.
5.6 BDNF increases the levels of phosphorylated Akt
Akt is a downstream target of activated PI3K and BDNF is known to activate Akt 
(Patapoutian & Reichardt, 2001; Huang & Reichardt, 2003; Chao, 2003). To 
determine if BDNF exposure alters the phosphorylation pattern of Akt, P0 
nodose neurons were plated in neurotrophin free medium for two hours then 
exposed to BDNF for times ranging from 5 to 120 mins. The cells were then 
lysed and antibodies that specifically recognize phosphorylated-Akt and non- 
phosphorylated Akt were used to probe western blots. BNDF exposure was 
found to increase levels of phosphorylated Akt after 5 minutes (Fig 49), which 
subsequently returned to basal levels after two hours. This demonstrates that 
BDNF-signalling increases the levels of activated Akt in nodose neurons.
Treatment of sensory neurons with either wortmannin or LY294002 have been 
shown to decrease the growth of BDNF-supplemented nodose neurons, and
164
BDNF exposure increases the levels of phosporylated Akt. This suggests a key 
role for the PI3K-Akt pathway in the positive regulation of BDNF-promoted 
neurite growth from developing nodose ganglion sensory neurons, when these 
neurons are extending axons and developing connections in their targets. 
Because RANK negatively regulates neurite growth from these neurons it seems 
unlikely that Akt is a necessary signal transducer for this effect of RANK.
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Figure 47: Effect of wortm annin on BDNF-dependent growth in sensory neurons.
P0 nodose neurons were treated with either wortmannin (50nM) or DMSO (control) for 
two hours prior to the addition of BDNF (10ng/ml). The neurons were fluorescently 
labelled with Calcein-AM dye and images were digitally acquired for analysis of neurite 
growth and morphology 24 hours after plating. Percentage survival after 24 hours (A). 
Sholl analysis (B), total neurite length (C) and number of branching points (D). The 
results are derived from the grouped data of three independent experiments. Statistical 
comparison are with respect to DMSO treated neurons (*p<0.05,***p<0.001, ANOVA with 
Fisher’s post hoc).
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Figure 48: Effect of LY294002 on BDNF-dependent growth in sensory neurons. P0
nodose neurons were treated with either LY294002 (50[jM) or DMSO for two hours prior 
to the addition of BDNF (10ng/ml). The neurons were fluorescently labelled with Calcein- 
AM dye and images were digitally acquired for analysis of neurite growth and morphology 
24 hours after plating. Percentage survival after 24 hours (A). Sholl analysis (B), mean 
total neurite length (C) and mean number of branching points (D). The results are derived 
from the grouped data of three independent experiments. Statistical comparison are with 
respect to DMSO treated neurons (***p<0.001, ANOVA with Fisher’s post hoc).
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Figure 49: BDNF increases the phosphorylation of Akt in sensory neurons. Western 
blots showing phospho-Akt and total Akt in PO nodose neurons treated with 10ng/ml 
BDNF for times ranging from 5 to 120 min (0 represents cultures not treated with BDNF). 
These experiments were repeated three times with consistent results.
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Figure 48: Effect of PI3K inhibitors on BDNF dependent-growth in sensory neurons. (A)
Photomicrographs of typical PO nodose neurons incubated for two hours with inhibitor before 
the addition of BDNF and imaged at 24 hours. Scale bar = 50pm. (B) Proposed pathway for 
the role of Akt in BDNF mediated neuronal growth.
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5.7 Discussion
I have provided evidence for roles for the important intracellular mediators MEK 
and PI3K in the regulation of neuritic outgrowth from developing nodose ganglion 
sensory neurons. Inhibition of the MEK in PO nodose neurons, prior to BDNF 
treatment, increased mean total neurite length and mean number of branch 
points by around 50% without affecting survival. MEK is a key upstream 
regulator of ERK activation and ERK positively regulates neuritic growth in many 
neuronal populations including embryonic chick retinal neurons, cultured 
hippocampal neurons and sympathetic neurons (Perron & Bixby, 1999; 
Veeranna et al., 1998; O’Keeffe et al., 2008). BDNF signalling is known to 
activate MAPK signalling pathways, including ERK (Patapoutian & Reichardt, 
2001; Huang & Reichardt, 2003; Chao, 2003), therefore the finding that MEK 
negatively regulates BDNF-promoted neurite growth in nodose neurons is 
surprising. These inhibitors are highly selective for MEK, making the possibility of 
this effect being due to the inhibition of another target unlikely.
In order to clarify the role of ERK in the regulation of BDNF-mediated neuronal 
growth in nodose neurons, levels of phosphorylated ERK were quantified 
following exposure to BDNF. ERK is the only known MEK substrate (Shaul & 
Seger, 2007) and ERK is known to be activated by BDNF signalling (Patapoutian 
& Reichardt, 2001; Huang & Reichardt, 2003; Chao, 2003). However, exposure 
of sensory neurons to BDNF did not apparently change the levels of 
phosphorylated ERK. Basal levels of ERK phosphorylation, however, were high
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in this particular experimental paradigm. Repetition of this experiment, following 
a longer period of incubation of the neurons to determine whether basal levels of 
phosphorylated-ERK decrease, may allow clarification of the relationship 
between BDNF signalling and ERK phosphorylation levels in nodose neurons. 
Alternatively, basal levels of phosphorylated-ERK may be high due to 
constitutive activation of ERK via MEK. This may constitute a BDNF-independent 
activation of MEK, possibly by an upstream regulator, and may be vital for the 
role of MEK in the negative regulation of BDNF-mediated neuronal growth.
The findings that MEK negatively regulates BDNF-mediated neuronal growth and 
that the levels of phosphorylated ERK are unaltered by exposure of nodose 
neurons to BDNF are surprising and in contradiction to the known roles of these 
kinases in the regulation of neurotrophin signalling. The possible activation of 
ERK, via MEK, independently of BDNF signalling to limit BDNF-promoted 
neuronal growth, is a novel mechanism for the regulation of the growth of 
sensory neurons. If MEK activation limits BDNF-promoted neuronal growth, 
either via ERK or via an unknown mechanism, then the inefficacy of BDNF to 
alter phosphorylated ERK levels is unsurprising. This intriguing situation warrants 
further exploration and may suggest a fundamental role for MEK/ERK in the 
negative regulation of BDNF-mediated neurite growth in sensory neurons. The 
use of expression and dominant negative constructs directed against the ERK 
signalling cascade, for example ERK and MEK expression plasmids, dominant 
negative ERK and MEK expression plasmids, and siRNAs directed against both
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of this kinases, will further our understanding of the role of this important 
intracellular pathway in the regulation of BDNF-mediated neurite growth in 
sensory neuronal populations. The exploration of possible upstream regulators of 
MEK activity may also expand our knowledge of the regulation of BDNF- 
mediated neuronal growth in nodose neurons.
The inhibition of MEK was only found to increase neurite growth when MEK was 
inhibited prior to the addition of BDNF to the culture. Prior or concurrent addition 
of BDNF with the MEK inhibitor prevented this increase, suggesting the effect of 
blocking MEK may only be effective if TrkB signalling has not been activated. 
The negative effect of MEK signalling on BDNF regulated neurite growth may be 
dependent on a specific section of the TrkB signalling cascade, such as Ras or 
Raf, key transducers in the activation of MEK by BDNF (Kaplan & Miller, 2000). 
Further studies to elucidate the mechanism by which MEK reduces the ability of 
BDNF to promote neurite outgrowth are necessary to explore the role of this 
kinase in the regulation of neuronal growth. Blocking MEK activity also did not 
prevent the inhibition of neurite outgrowth seen when over-expressing RANK, 
suggesting that the ERK signalling cascade is not crucial for the inhibitory effects 
of exogenous RANK expression on neurite growth in this sensory neuronal 
population.
The role of Akt in BDNF signalling in sensory neurons was also investigated. 
Nodose neurons incubated with PI3K inhibitors, prior to the addition of BDNF,
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grew significantly less than controls. Surprisingly, inhibition of PI3K has no effect 
on the survival of neurons cultured in BDNF. Exposure to this neurotrophin 
increased the levels of phosphorylated-Akt after five minutes and levels of 
phosphorylated-Akt then returned to initial quantities after two hours. These 
results suggest a role for PI3K in the positive regulation of BDNF-mediated 
neurite growth in nodose neurons.
The primary role of Akt in neurons is in the regulation of survival and Akt has 
been implicated as a key signalling protein for growth factor-dependent survival 
of a wide variety of cell types (Datta et al., 1999). PI3K is necessary and 
sufficient for growth factor-dependent activation of Akt (Burgering & Coffer, 1995; 
Alessi et al., 1997) and Akt is a key regulator of NGF-dependent survival. 
However, other studies have found that while Akt is necessary for the NGF- 
supported survival of sympathetic neurons, PI3K may not be (Philpott et al., 
1997; Tsui-Pierchala et al., 2000). Akt is also known to be activated by BDNF 
(Patapoutian & Reichardt, 2001; Huang & Reichardt, 2003; Chao, 2003) and the 
survival effect of BDNF has been found to be dependent on PI3K (Atwal et al., 
2000). Therefore, the lack of a survival effect when blocking PI3K in sensory 
neurons supported by BDNF is surprising. However, Akt is also known to have a 
role in positively regulating the growth of many cell types including cerebellar 
(Dudek et al. 1997), sympathetic (Philpott et al., 1997; Crowder & Freeman, 
1998; Vaillant et al., 1999; Atwal et al., 2000), sensory (Gallo, & Letourneau, 
1998; Liu & Snider, 2001) and striatal neurons (Gavalda et al., 2004). These
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results provide further evidence that PI3K is important in the promotion of neurite 
growth by BDNF. Additional investigation, using Akt or PI3K expression 
plasmids, dominant negative constructs directed against PI3K and Akt and the 
use of siRNAs directed against these kinases, will increase our understanding of 
the role this signalling cascade plays in the regulation of BDNF-mediated neurite 
outgrowth in sensory neurons.
One of the most striking findings of these studies is the contrast between ERK 
and Akt signalling and the opposing roles these important signalling members 
play in the regulation of BDNF-mediated neurite outgrowth from sensory 
neurons. PI3K and MEK are both activated by BDNF and Ras transduces TrkB 
activation to both of these intracellular mediators (Kaplan & Miller, 2000), 
suggesting Ras could be a focal point for the regulation of neuronal growth by 
these kinases. Experiments designed to investigate the role of Ras, such as 
inhibitors directed against this protein, and other important downstream effectors, 
will be essential in increasing our understanding of the role of these intracellular 
mediators in BDNF-promoted neuronal growth. Further exploration of the role 
MEK and PI3K play in the regulation of the development of sensory neurons, 
including in the action of other neurotrophins, such as NT-4, and cytokines, such 
as CNTF, will expand our knowledge of the way these neurons are regulated at 
this crucial time in the development of their neuritic arbors. Exploration of 
whether PI3K and MEK play similar roles in the regulation of growth and survival 
in the small subset of NGF-responsive nodose neurons (Forgie et al., 2000)
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would also be interesting. NF-kB has recently been shown to display a 
developmental shift in the regulation of neurite growth in sensory neurons 
(Gavalda et al., 2009). Therefore, studies of the actions of PI3K and MEK at 
earlier and later stages in development will also increase our knowledge of the 
function of these intracellular signalling members in the development of sensory 
neurons. The findings reported in this chapter not only provide evidence for novel 
roles for MEK and PI3K in the regulation of neuronal growth, but form the basis 
of an important body of future research.
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General Discussion
The growth and survival of neuronal populations are regulated by a variety of 
different molecules. Members of the neurotrophin family, the neurotrophic 
cytokines and other signals regulate these processes and are secreted by a wide 
variety of cells to support neuronal populations (Davies, 2003). Members of the 
TNF superfamily have recently been found to regulate the growth of several 
populations of neurons including GITR in sympathetic neurons and LIGHT in 
sensory neurons (O’Keeffe et al., 2008; Gavalda et al., 2009). I have provided 
evidence for a novel role for the TNFR superfamily member, RANK, in the 
regulation of neuritic growth from sensory neurons of the nodose and trigeminal 
ganglia, and sympathetic neurons of the SCG. RANK, along with the ligand for 
this receptor, RANKL, and a decoy receptor, OPG, were found to be present in 
all neurons of these ganglia. Over-expression of RANK significantly reduced the 
neuritic growth from all of these neurons, when cultured in the appropriate 
neurotrophic factor that supports their survival and growth, across a wide range 
of developmental timepoints from embryonic stages to postnatal ages.
Investigations into the intracellular mediators vital for the effect seen when over­
expressing RANK in neurons of the nodose ganglia, via co-transfection of the 
RANK expression plasmid together with dominant negative expression plasmids 
targeted at known RANK-associated signalling mediators, revealed the
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requirement of TRAF2, NIK, IKKp and NF-kB. Inhibition of each of these 
mediators prevented the effect seen when over-expressing RANK on BDNF- 
mediated neuritic growth. TRAF6 and IKKa were found to not be required for the 
effect of over-expressing RANK. These signalling mediators constitute a distinct 
pathway in the regulation of RANK signalling in sensory neurons that differs 
significantly from previously published work (Darnay et al, 1998; Darnay et al.,
1999).
Further investigations into the role of RANK, along with the ligand for this 
receptor, and the decoy receptor for RANKL, in the regulation of the 
development of neuronal populations, including the use of RANK deficient mice 
(Dougall et al., 1999; Li et al., 2000), will increase our knowledge of the role of 
this TNF receptor superfamily member in the regulation of neuronal 
development.
The roles of Akt and ERK, in the regulation of neuronal growth and survival, are 
well characterised and both have been shown to be vital for neurotrophin- 
mediated survival and outgrowth (Kaplan & Miller, 2000; Liu & Sinder, 2001). 
The finding that Akt positively contributes to BDNF-mediated neuritic outgrowth 
in sensory neurons is thus unsurprising, given the role of this kinase in other 
neuronal populations. The finding that ERK negatively regulates BDNF-mediated 
neuritic outgrowth, however, is very surprising. It has been posited that signalling 
by neurotrophins activates Trk receptors which then trigger ERK activation and
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that this instructs morphological responses (Liu & Snider, 2001; Kaplan & Miller,
2000). This does not appear to be the case with sensory neurons of the nodose 
and the role of this kinase in the regulation of sensory neuron development 
warrants further investigation. Figure 51 show a graphic representation of the 
results contained with this thesis.
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Figure 51: Summary of results. RANK decreases neurite growth in nodose, 
SC G  and trigeminal neurons. In nodose neurons RANK signals via TRAF2, 
NIK, IKKB and NF-7B. BDNF signals via Akt in nodose neurons and ERK acts 
to limit B DN F mediated neurite growth.
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